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1. ABSTRACT 
 
Bioresponsive hydrogels are emerging with technological significance in targeted 
drug delivery, biosensors and regenerative medicine.  The design challenge is to 
effectively link the conferred biospecificity with an engineered response tailored to the 
needs of a particular application. Moreover, the fundamental phenomena governing the 
response must support an appropriate dynamic range, limit of detection and the potential 
for feedback control. The design of these systems is inherently complicated due to the 
high interdependency of the governing phenomena that guide sensing, transduction and 
actuation of the hydrogel.  The objective of the dissertation is to review the current state 
of bioresponsive hydrogel technology and introduce a method of extending the 
technology through integrated control loops; explore fundamental phenomena which 
affect ion transport within biomimetic hydrogels; and investigate, via in silico studies,  
the fundamental design parameters for the implementation of a feedback control loop 
within a bioresponsive hydrogel.  
In one study, effects of valence number, temperature and polymer swelling on 
release profiles of monovalent potassium and divalent calcium ions elucidates 
mechanistic characteristics of polymer interactions with charged species.  For 
comparison, ions were loaded during hydrogel formulation or loaded by partitioning 
following construct synthesis. Using the Korsmeyer-Peppas release model, the 
diffusional exponents were found to be Fickian for pre- and post-loaded potassium ions 
while preloaded calcium ions followed an anomalous behavior and postloaded calcium 
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ions followed Case II behavior. Results indicate divalent cations interact through cation-
polyelectrolyte anion complexation while monovalent ions do not interact with the 
polymer.  Temperature dependence of potassium ion release was shown to follow an 
Arrhenius relation and calcium ion release was temperature independent.   
In another study, data generated from the previous Chymotrypsin system is used 
to build and validate a finite element model.  The model provides insight into key 
engineering parameters for the design of an enzymatically actuated, feedback controlled 
release.  A drug delivery platform comprising a biocompatible, bioresponsive hydrogel 
and possessing a covalently tethered peptide-inhibitor conjugate was engineered to 
achieve stasis, via a closed control loop, of the external biochemical activity of the 
actuating enzyme.  The FEM model was used to investigate the release of a competitive 
protease inhibitor, MAG283, via cleavage of Acetyl-Pro-Leu-Gly|Leu-MAG-283 by 
MMP-9 in order to achieve targeted homeostasis of MMP-9 activity, a goal for the 
treatment of chronic wound pathophysiology. It was found the key engineering 
parameters for the delivery device are the radii of the hydrogel microspheres and the 
concentration of the peptide-inhibitor conjugate loaded into the hydrogel.  
Homeostatic drug delivery, where the focus turns away from the drug release rate 
and turns towards achieving targeted control of biochemical activity within a biochemical 
pathway, is an emerging approach in drug delivery methodologies for which the potential 
has not yet been fully realized.  By understanding mechanistic phenomena and key 
engineering parameters for design, advancements in bioresponsive hydrogels will 
continue to produce novel technologies in biomedical applications.  
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CHAPTER ONE 
1. BIORESPONSIVE HYDROGELS 
1.1. Introduction 
Biologically responsive (bioresponsive) hydrogels are stimuli responsive 
hydrogels wherein the response of the hydrogel is triggered by recognition of a biological 
agent by an immobilized biorecognition species.  Biological agents may be biomolecules 
like glucose
[8]
, large macromolecules like chymotrypsin 
[9]
, or even whole cells, such as 
vascular endothelial cells 
[10, 11]
.  Biorecognition species can be native or synthetic 
biomacromolecules such as enzymes, antibodies, nucleic acids 
[12-15]
, or small molecules 
such as metabolites or peptides 
[16, 17]
.  The triggers may result in responses which 
include, among others: swelling or collapsing, degradation, mechanical deformation, 
optical density changes, or electrokinetic variations 
[18]
. The response may be binary, as 
in presence or absence of the biological agent at a particular threshold limit, or it may be 
scalable with the chemical potential or activity of the biological agent 
[19-21]
. 
Bioresponsive hydrogels link hydrogel responses to innate specificity of bio-recognition 
reactions which enables them to elicit a response upon meeting specific criteria 
[22]
.  This 
creates a “smart” material because it is able to sense surrounding biological agents and 
can remain in stasis or become dynamic depending on changes in the surrounding 
environment 
[23, 24]
. Bioresponsive hydrogels may share features with, but are 
distinguished from, biomimetic hydrogels that contain elements of chemistry, structure, 
architecture, morphology and materials properties intended to mimic local biological 
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properties and from bioactive hydrogels that contain elements intended to participate 
within known biochemical pathways. 
The engineering of bioresponsive hydrogels is often difficult because:  i) 
molecular and architectural design must be properly specified and fabricated, ii) there are 
biologically imposed constraints in conditions of materials processing, and iii) there are 
complex interactions between the hydrogel matrix, the conferring bioactive species, the 
targeted biological agent, and the solvent (usually water) during performance. Successful 
design requires multiple length scale theoretical and experimental modeling to control 
kinetic, thermodynamic, and transport phenomena 
[25-28]
.  Additionally, immobilization of 
the biorecognition species must be achieved while maintaining its bioactivity. 
The utility of bioresponsive hydrogels is vividly apparent in their applications. 
These hydrogels have been used in tissue engineering 
[29, 30]
, in mediated drug delivery 
[31-
33]
, and biosensing applications 
[34-37]
. In tissue engineering, bioresponsive hydrogels have 
been used as biomimetic matrices, which promote cellular proliferation but also 
biodegrade over time. In drug delivery, it is commonly desired to deliver a drug in 
specified doses to a specific site, organ, or biological system 
[38-40]
.  Bioresponsive 
hydrogels are capable of location specific delivery because they are able to release the 
therapeutic drug payload when they are triggered by biologically derived, site-specific 
stimuli 
[41]
. In sensor applications, bioresponsive hydrogels can produce a measurable 
response when a specific analyte of biological origin is present 
[42]
.   
Below, fundamental design and applications of bioresponsive hydrogels will be 
discussed to highlight their capabilities.  In this discussion, considerations in the design 
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of bioresponsive hydrogels will be given, which focus on information flow control, 
incorporation of control loops into the material and fundamental phenomena in the design 
of bioresponsive hydrogels.  Subsequently, previously engineered systems will be 
discussed to demonstrate approaches and methods of designing bioresponsive hydrogels 
utilizing various physical phenomena for sensing, transduction and the response. 
1.2. Design Considerations of Bioresponsive Hydrogels 
1.2.1. Biological Event, Transduction-Signal Creation and Response 
Figure 1-1 illustrates the overarching platform technology in the form of a process 
flow diagram that outlines the three main steps of the general mechanism by which a 
biological agent creates a response within a hydrogel.  (1) A biological agent comes into 
contact with the hydrogel.  It is “sensed” by a biorecognition species within the hydrogel 
through binding or catalysis.  (2) Transduction occurs by perturbing the thermodynamic 
equilibrium of the bioresponsive hydrogel through chemical potential created by the 
recognition reaction.  (3)  A response occurs as the hydrogel system restores 
thermodynamic equilibrium based on the new conditions.  To exemplify this process 
consider the case where a substrate (bioactive agent) diffuses into a bioresponsive 
hydrogel with an immobilized enzyme (biorecognition species). The enzyme will first 
complex and begin to catalyze the substrate (biological event).   The concentration, or 
chemical potential, of substrate present within the hydrogel will determine the rate of 
substrate catalysis (transduction).  Product will be continuously formed until the 
thermodynamic equilibrium is reestablished (response).   
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An additional step, Step 4, an integrated control loop, is also illustrated in Figure 
1-1 and discussed in the subsequent section. Considering the previous example, this could 
occur when appearance of the product induces a collapse of the hydrogel which reduces 
the diffusivity of the substrate into the hydrogel; in which case the chemical potential of 
the substrate will have a self-limiting effect (feedback) on the response of the hydrogel. 
1.2.2. Next Generation Bioresponsive Hydrogels – Closing the Loop 
The historical development of bioresponsive hydrogels has proceeded with 
incremental advances to a broadening base of scientific knowledge.  Responsive 
hydrogels began with polymers which were able to sense and respond to environmental 
stimuli such as temperature and pH (Generation 1).  Further development led to 
bioresponsive hydrogels which sense biological agents pertinent to specific biological 
systems, pathways, or processes (Generation 2).  Development and optimization of 
Figure 1-1:  Information flow scheme of bioresponsive hydrogels. 
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bioresponsive hydrogels has improved and forged new applications in a variety of fields; 
however, to continue their advancement a fundamental design concept is required in the 
information flow scheme. That is, the inclusion of closed control loops integrated into the 
hydrogel such that the hydrogel material and the surrounding environment operate as a 
cohesive system (Generation 3). Gen3 hydrogels’ responses effect and are affected by 
upstream or downstream processes in a manner which potentiates or attenuates biological 
activity accordingly.  These materials will function as a synthetic metabolic pathway 
capable of therapeutically administering drugs personalized to a patient’s biological 
activity 
[43]
.   
Conceptualization of an integrated feedback loop has existed for some time
[44]
, 
and proposed platforms based on pH sensitivity or binding affinity have been 
demonstrated experimentally 
[8, 16, 45]
.  Balazs and Aizenberg illustrate this capability with 
regard to thermo- and mechano-responsive polymer control systems 
[46]
.  Others have 
demonstrated in silico systems which provide methods for parameter optimization
[47, 48]
.  
In all, these examples have been building towards full biomolecular integration; however, 
in vitro and in vivo demonstration of full integration is only beginning to be developed 
[49]
. This is exemplified in the glucose responsive hydrogels of Guiseppi-Elie et al 
[8]
, 
where insulin was released based on exposure to glucose emulating the natural endocrine 
response; however, because the necessary metabolic pathways needed to affect the 
solution concentration of glucose were not present, the system’s response (a change in the 
rate of release of insulin) was not informed by a change in the concentration of glucose.  
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Other potential applications for Gen3 hydrogels exist in cancer 
[50, 51]
, opiate based 
therapeutics
[52]
, HIV therapy 
[53, 54]
, and anesthesia 
[55]
. 
The integration of control loops into bioresponsive hydrogels offers two distinct 
advantages over existing technologies:  (1) reduction of multiple discrete components 
required for control loops into one material and (2) tighter control over therapeutic 
delivery enabling therapies which were not previously achievable.  The components of a 
typical control scheme are a sensor-transducer (glucose sensor), an electrical controller 
(computer) and an actuation-response (insulin pump) device which is exemplified in 
Figure 1-2.   Gen3 hydrogels intrinsically perform the operation of all three devices 
Figure 1-2:  Current blood glucose monitoring system, as outlined by the FDA, involving 
a glucose sensor, controller, and insulin pump can be reduced to a single polymeric 
material, a glucose sensitive hydrogel 
[1]
. 
 7 
 
reducing the system into one material which can be synthesized at the nanoscale.  The 
first in vivo demonstration of a Gen3 hydrogel is given by, Gordijo (2011), where blood-
glucose concentrations are controlled by a glucose-responsive, insulin-releasing 
hydrogel
[49]
.  Others have developed in vitro closed loop systems for chemomechanical 
pumps 
[56]
, chemostatis 
[57, 58]
 and chemomechanical microvalves
[59, 60]
.  While these 
systems are based on phase transition behavior, there are unexplored opportunities to 
couple such systems with bioresponsive hydrogels for novel applications.  The other 
advantage of Gen3 hydrogels is the extension and improvement of current therapeutic 
delivery devices.   Where current administration of therapeutic molecules may involve 
time intensive assaying of samples, dosing amounts inconsequential of metabolic activity 
or systemic delivery of molecules reducing efficiency and efficacy, Gen3 hydrogels sense 
local metabolic activity and administer therapies spatiotemporally in biologically relevant 
doses.   
1.2.3. Control Theory in Bioresponsive Hydrogels 
Control theory in Gen3 hydrogels is applied to two processes, the intrinsic 
metabolic process and the engineered sense and response of the hydrogel. Control theory 
in metabolic processes is a continually growing field with developed models for natural 
metabolic feedback and feedforward control loops 
[61, 62]
.  Control theories are being used 
to understand processes such as natural, closed-loop blood glucose control 
[63]
, 
neurological disease 
[64]
, and regulation in cellular networks 
[65]
.   Conversely, the control 
theory around Gen3 hydrogels has not been extensively developed.  Current control loops 
involve a controller device, the controller in Figure 1-2, which can be programed with the 
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appropriate control schemes, PID or SPID being most common in biological applications 
[66].  The “programming” of Gen3 hydrogels is fundamentally different as tuning of 
physical parameters, such as diffusion constants, loading concentrations or swelling 
properties, will be used to effect time constants, τi, and gains, Ki .   
Two classical control loops, feedback and feedforward, are illustrated in Figure 
1-3A.  Additionally, the associated block diagram with transfer functions for a feedback 
control loop is shown in Figure 1-3B.  In this diagram, the metabolic processes under 
control, such as a single or multiple enzymatically catalyzed reactions, are shown as one 
transfer function,   
  .  The transfer functions for transport of the biological moiety 
which will be sensed by the hydrogel,   
       
, the sensing event,   
    
, the 
transduction of the sensing signal,    
 , and the response,    
 , are shown as separate 
transfer functions.  The setpoint, βsp, is the biological activity of some moiety, such as a 
local enzyme activity or concentration of an analyte, and is selected based on the desired 
outcome of the engineered system.  The error signal, E, is the difference between the 
current activity of the bio-moiety and the setpoint, is zero when the current activity 
equals the desired activity, and deviates away from zero when disturbances are 
introduced into the system.  A notable difference between classic control systems and 
control loops integrated into hydrogels is that classical control systems have discretely 
identifiable components, such as sensors, transducers and actuators, while hydrogels 
integrate all functionality of the separate components into a single material; however, like 
classic control systems it is key to appropriately tune the hydrogel, through physical 
parameters such as reaction rates or effective diffusivities, to achieve the desired control.   
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Figure 1-3:  (A) Conceptualization of feedback and feedforward control loops using 
bioresponsive hydrogels.  (B) Block diagram with transfer functions for positive or 
negative feedback control loop. 
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An example of molecularly engineered feedback control loops was demonstrated 
by Gu 
[67]
, wherein, glucose-actuated, insulin-releasing hydrogels exhibited closed loop 
control of blood glucose concentration in a type 1 diabetic mouse model.  Nanocapsules 
containing glucose oxidase and insulin were incorporated into chitosan hydrogel 
microspheres and injected into the subcutaneous dorsum of the mouse.  Glucose oxidase, 
acting as a combined sensor-transducer, catalyzed local glucose into gluconic acid 
consequently decreasing the local pH.  The protonatable chitosan, acting as a combined 
transducer-actuator, swelled in response to the altered pH and thereby increased the 
effective diffusivity of the entrapped insulin.  Released insulin, acting through insulin 
receptors on cells, increases consumption of glucose thereby reducing the blood glucose 
to the set point, normal blood glucose level. The system was capable of responding to 
disturbances in glucose levels. Development of transfer functions for each process; 
sensing, transduction and response, will depend on the molecular phenomena involved in 
each step.  In sensing, diffusion-reaction phenomena will need to be appropriately 
modeled and subsequent transfer function developed 
[68, 69]
.  For transduction, the transfer 
function will depend on how information is processed through temporal chemical 
potentials. A transduction transfer function can be exemplified by the Laplace 
transformation of Equation (1) 
[70]
, a simple model for pH dependent polymer swelling, 
into Equation (2). 
 
 
  ( )
  
  ( )     ( ) (1) 
 
   
  
  ( )
   ( )
 
 
    
 (2) 
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Where Q(t) and pH(t) are the time dependent swelling ratio and pH of the hydrogel, 
respectively; Q’ and pH(t)’ indicate deviation variables of the respective parameters; and 
   
  is the transduction transfer function for changes in swelling ratio from changes in 
pH.  Transfer functions of the response will be determined by underlying phenomena 
such as diffusion-reaction, mechanical, optical or electrochemical.  For further reading of 
control theory in biological applications, the reader is directed elsewhere 
[61, 71]
. 
1.2.4. Polymer Characteristics and Effects in Bioresponsive Hydrogels 
In bioresponsive hydrogels, interactions between biological species and moieties 
or architecture within the polymer play a key role in the materials’ ability to sense and 
respond to changes in its environment. For the polymer, key characteristics which will 
affect performance include, but are not limited to, network morphology, biocompatibility 
and environmental responsiveness.   
Network morphology describes the orientation of polymer chains and void spaces. 
It directly affects transport and mechanical properties altering movement of biological 
agents within and affecting cellular response to the hydrogel 
[72-74]
.  Polymer swelling 
theory, originally developed by Flory and Huggins(1943) and extended by others, enables 
the determination of quantitative parameters describing structural characteristics of 
swollen hydrogels which includes:  degree of hydration (DoH), swelling factor (Q), void 
fraction (ε), tortuosity (τ), the average molecular weight between crosslinks ( ̅ ), cross-
linked density (     ⁄ ) and the pore or mesh size ( ).  Void fraction is a measurement of 
the space occupied by the pores within hydrogel. Tortuosity is a ratio of the transport path 
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taken through the pores to the measured thickness of the hydrogel.  Degree of hydration, 
expressed as a percentage, DoH, is the ratio of the amount of water taken up by the 
hydrogel to the weight of the hydrated hydrogel.  The swelling factor, Q, represents the 
ratio of the volume of the swollen hydrogel, Vs, and the polymer volume, Vp.  Cross-
linked density, (     ⁄ ), is the molar concentration of crosslinks.  The parameter  ̅  
represents the average molecular weight of polymer chains between neighboring cross-
links or junctions. The network mesh or pore size, ξ, is determined by the average 
distance between cross-linked points in the gel and thereby describes the degree of 
hydrogel porosity.  A schematic illustration of  ̅  and ξ in a two-dimensional rendering 
of a water-swollen hydrogel is shown in Figure 1-4.   
 
 
 
Figure 1-4:  Schematically illustrates the concept of swelling of a hydrogel by the 
imbibition of water. 
 13 
 
Table 1-1:   Table of equations for parameters which fully characterize the network 
morphology and polymer structure of a hydrogel. 
Parameter Equation  Measurement REF 
DoH 
     
  
      (3) Weight [9] 
Q   
  
  
 
 
    
 (4) Volume 
[75]
 
εi    (
  
         
) (5) Weight, Volume [9] 
τ          
 
 
 (6) 
Diffusivity, 
Effective 
Diffusivity, 
Weight, Volume, 
Partitioning 
[9]
 
 ̅     
   
 ̅ 
(  
  ̅ 
 ̅ 
) (  
 
  
) (
    
    
)
  ⁄
 (7) 
Volume, Tensile, 
DLS or HPLC 
[76-78]
 
[
  
 
]    [
  
 
]
  (     
  )
(        ⁄ )
  ⁄
 (8) Volume, Tensile 
[79]
 
ξ 
[
    
 
]
  ⁄  
 
(9) Volume, Tensile 
[79]
 
 
Where i is the state of the polymer (s = swollen, d = dehydrated, r = relaxed), M is the 
weight of the hydrogel, ρ is density, Deff is the effective diffusivity of a moiety within the 
hydrogel, KP is the partitioning coefficient, D0 is the diffusivity of a moiety in the 
hydrating buffer, τs is the stress at a particular strain, R is the ideal gas constant, T is 
temperature,  ̅  is the molecular weight of the polymer chains prepared under identical 
conditions without cross-linker, α is the elongation ratio,      and      are the polymer 
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volume fractions in the swollen and relaxed state, respectively, αs is the ratio of deformed 
length over original length under compression and NA is Avogadro’s number.  
Combing polymer swelling theory with transport models based on hydrogel 
morphology, Table 1-2, enables powerful predictive capabilities in bioresponsive 
hydrogels.   For more robust treatment of the polymer swelling theory and its effects on 
transport phenomena, the reader is directed Peppas et al. 
[76, 82]
. 
Table 1-2:  Diffusive transport theories as they apply to hydrogel morphologies.  
Theory Hydrogel Morphology Governing Equation  Ref 
Free Volume Porous 
    
(  )  
 
 
(10) [76, 92, 93]  
Free Volume Nonporous, Highly Swollen    
   
   (
 ̅   ̅ 
 
 ̅   ̅  
)    (
     
 
   
) 
(11) [76, 93, 94] 
Hydrodynamic Micro-Porous    
  
 (   ) (            ) 
(12) [76, 93, 95]  
Obstruction Porous             
 
 
 (13) [76, 93, 96] 
 
Where Dip is the diffusion coefficient of species i in the polymer matrix; Db is the 
diffusion coefficient of the solute through the bulk; Diw is the diffusion coefficient of 
species i in the solvent; λ* is the diffusional jump length of the solute; υ is the jump 
frequency; Mc is the average molecular weight between crosslinks; Mn is the average 
molecular weight of the polymer without crosslinks; Mc
*
 is the critical molecular weight 
between crosslinks; Q is the degree of swelling; λ is the ratio of the solute radius to the 
average pore radius or mesh size; α, β, and γ are constant dependent on the system; Kp is 
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the partitioning coefficient; and Kr is the fractional reduction in diffusivity as the solute 
diameter approaches the pore diameter. 
Performance of bioresponsive hydrogels can be negatively affected if the polymer 
is not biocompatible as protein fouling or the inflammatory response can inhibit transport 
of biological agents, by degradation of the biological agents or through fibrous 
encapsulation, required for triggering or compromise the immobilized biorecognition 
species.   Material’s Science has sought to passively reduce fouling by reducing 
interfacial energy between biological fluids and the polymer, promoting entropic 
repulsion to inhibit proteins from approaching surfaces, and increasing the strength of 
water-polymer interactions above polymer-protein interactions 
[83]
.  Conversely, 
bioresponsive hydrogels can actively reduce protein fouling by surface immobilization of 
the thrombin inhibitor, heparin 
[84]
 , degrading fibrin networks by activation of 
plasminogen 
[85, 86]
, controlled release of modified heparin 
[87]
 or self-cleaning via thermal 
cycling 
[88]
 .  Additionally, the reduction of inflammatory response has also been 
demonstrated in bioresponsive hydrogels through immobilization of MMP inhibitors 
[89]
, 
cytokine-inhibitory peptides 
[90]
, or cell mediated release of dexamethasone 
[91]
. 
 Polymer characteristics can be heavily dependent on environmental parameters.  
Flory-Rehner theory was originally developed to describe the environmental effects on 
entropic polymer relaxation (rubber elasticity theory)
[80]
 and free energy dependent 
swelling (equilibrium solvation theory)
[97]
.  Extensions of the theories have included 
LCST prediction 
[98, 99]
 and pH dependence.  pH, more often than temperature in 
bioresponsive hydrogels, is used to effect polymer solvation which directly can change ε, 
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τ, E and  .  Swelling relations for cationic and anionic polymers prepared in the presence 
of solvent are given in Equations (14) and (15), respectively. 
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(15) 
Where I is ionic strength and Ka and Kb are the acid and base dissociation constants, 
respectively 
[76]
.  Performance of biorecognition species immobilized in bioresponsive 
hydrogels can affect 
[100, 101]
 or be affected 
[102]
 by the dynamic solvation of 
environmentally responsive polymers.  In this manner, the ability to affect polymer 
characteristics is leveraged as a transduction mechanism in bioresponsive hydrogels. 
1.2.5. Reaction-Diffusion Considerations in Bioresponsive Hydrogels 
In bioresponsive polymers chemical reactions and diffusive transport are 
inherently coupled as enzyme catalyzed or ligand binding reactions are the first step of 
the process flow. Often, complexities arising from coupled reaction-diffusion phenomena 
are eliminated by assuming a rate limiting mechanism, such as diffusive transport, 
chemical reaction kinetics, or polymer swelling, is governing the response rate 
[103]
.  In 
enzyme catalyzed systems, the rate limiting step can be determined by the Thiele 
modulus, Equation (16), a ratio of the reaction and transport rates which predicts φ<1 for 
reaction limited and φ>1 for transport limited cases[104, 105].   
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[
    
      
]
 
 
  (16) 
Where R is the characteristic length, α is a constant dictated by the geometry (α = 1, 2, or 
3 for slabs, cylinders, or spheres, respectively), φ is the Thiele modulus, Deff is the 
effective diffusivity constant, and KM and Vmax are the enzyme kinetic constants 
[106]
.  The 
Thiele modulus provides a method for optimization of enzyme catalyzed systems 
[9]
.  
Additionally, it has been developed for other cell 
[107]
 and antibody
[108]
 based systems, but 
these mathematical relations have yet to be utilized in bioresponsive hydrogels.  Other 
measures for competing rate phenomena include the Damkohler number (Da), Peclet 
number (Pe) and the mass transfer Biot number (Bi) 
[109]
, Equations (17) - (19).   
 
   
             
                         
 
(17) 
 
   
                        
                          
 
(18) 
 
   
                            
                                   
 
(19) 
While assuming a rate limiting step can be used to obtain a reasonable fit to 
experimental data, it is only an approximation and may eliminate opportunity for 
versatility often demonstrated by nature 
[110]
.  Conversely, reaction-diffusion phenomena 
in bioresponsive hydrogels can be resolved through explicit derivations, which may 
require simplifications for mathematical solutions, or by finite-element modeling, which 
can handle multiphysics modeling with the increase in computational power over recent 
decades.  Understanding and controlling reaction-diffusion phenomena in bioresponsive 
hydrogels has resulted in novel applications such as increasing throughput for protein 
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hydrogel-based microchips 
[111]
, determination of protein-ligand dissociation constants in 
the picomolar range 
[112]
 and insights into redox polymer based biofuel cells 
[113]
. 
1.2.6. Conferring Biospecificity to Hydrogels 
The design of bioresponsive hydrogels seeks to unite the conferred capacity for 
biorecognition of a bioreceptor with the capacity for a tailored response using unique 
macromolecular structures and architectures of the hydrogels. Biorecognition may be 
conferred through the immobilization 
[114]
 (physical entrapment, polyelectrolyte complex 
formation, covalent bonding, or adsorption) of biologically active moieties such as 
peptides, nucleic acids, enzymes, antibodies, antibody fragments, sub-cellular fragments, 
or whole cells. Most commonly, these are molecular entities such as peptides and nucleic 
acids which may be pendant to the hydrogel network backbone or may serve as covalent 
or virtual crosslinks. Hennink and Nostrum have reviewed cross linking methodologies in 
hydrogels 
[115]
.  
A widely used application of pendant peptide sequences is the attachment of the 
peptide Arg-Gly-Asp (RGD) which promotes receptor mediated cellular attachment via 
integrins 
[116]
. Additionally, peptide sequences can be immobilized within the hydrogel to 
create protease degradable hydrogels 
[117]
. A common example is the immobilization of a 
bioactive peptide that may be cleaved by an external proteolytic enzyme thus releasing a 
drug that diffuses out of the hydrogel. The early patents of Kopeček et al. [118, 119] describe 
the synthesis of polymers of N-2-(hydroxypropyl)methacrylamide (HPMA) and its 
copolymerization with reactive monomer for the subsequent covalent immobilization of 
bioactive entities such as enzymes, hormones and drugs. Similarly, the patent filing 
[120]
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and publications of Langer 
[120, 121]
 illustrates this enzyme mediated schema with a 
dextran-peptide-methotrexate conjugate cleavable by matrix metalloproteinases, MMP-2 
and MMP-9, for tumor-targeted delivery of the chemotherapeutic agent. These early 
patents teach and the publications clearly demonstrated the principle of enzyme mediated 
release. The subsequent work of Kopeček also illustrates this scheme within HPMA 
copolymerized with the cleavable tetrapeptide conjugate (Gly-Phe-Leu-Gly) of 
doxorubicin (DOX) directed at cancer therapy 
[122]
.  The tetrapeptide-conjugated, 
doxorubicin (DOX) containing degradable hexapeptide diacrylate [MA-(GFLG)-Orn-
(GLFG)-MA] crosslinked HPMA hydrogel was used to study how the molecular weight 
(22–130 kDa) of the peptide would affect treatment of OVCAR-3 human ovarian 
xenografts in nude mice 
[123]
. The results showed clearly the need for an appropriate 
molecular weight to promote long circulating times in circulating drug delivery and 
tumor targeting systems that exploit the enhanced permeability and retention (EPR) effect 
for the treatment of solid tumors 
[124]
. Covalent attachment as a strategy may exploit 
reactive functional groups, such as primary amines, acids and thiols of pendant moieties 
of the hydrogel backbone of the swollen hydrogel 
[119, 125]
 or may be synthesized as 
polymerizable monomer or pre-polymers that are directly polymerized into the network 
[24]
. This type of enzyme mediated delivery system is now well known and is the subject 
of further patents 
[126]
 and considerable predictive refinement 
[125]
. 
A special case is the targeting of MMP activity. MMPs are of particular interest as 
they are over expressed in both chronic wounds (pressure ulcers, diabetic ulcers, etc.) and 
in invasive solid tumors (e.g. gliblastoma multiforme) 
[127]
. Both environments 
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demonstrate deviations from homeostasis in the construction/destruction of the 
extracellular matrix 
[128]. The patent application of Trotter and Slloock entitled “enzyme 
sensitive therapeutic wound dressing” [129] illustrates the concept of enzyme mediated 
release in relation to MMP activity. Recently, Gemeinhart et al. have expanded upon this 
theme to demonstrate release of a fluorophore via the cleavage of a MMP-2 specific 
peptide sequence that was immobilized within a cross-linked poly(ethylene glycol) 
diacrylate hydrogel 
[130]
. Using the photoinitiated mixed-mode thiol-acrylate 
polymerization method of Anseth 
[131, 132]
, they achieved insertion of the thiol-terminated, 
MMP-2 specific, Rhodamine conjugated peptide sequences into the hydrogel backbone.  
Gemeinhart et al. 
[133]
 investigated the influence of molecular weight, conjugate loading 
and hydrogel mesh size on the MMP-2 mediated release of the fluorophore. A critical 
mesh size, commensurate with the hydrodynamic radius of MMP-2 was identified above 
which MMP-2 entered the hydrogel. 
The foregoing work is now being extended to the use of biologically responsive 
“smart” hydrogels, wherein, negative feedback control is achieved by enzyme mediated 
release of a factor which regulates the activity of a biological species outside the 
hydrogel, subsequently reducing the release rate of the factor. Living systems possess 
molecular mechanisms which allow them to maintain optimized physiological conditions, 
despite variations and disturbances to their environment. Homeostasis is thus a self-
adjusting mechanism involving negative feedback control. The design, synthesis and 
fabrication of biologically responsive hydrogels to achieve homeostasis in external 
biological activity is a novel, and until now, an unexplored concept. 
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A reverse of the foregoing, the immobilization of an enzyme within the hydrogel, 
is likewise feasible. Such configurations are commonplace in the construction of enzyme 
amperometric biosensors 
[134]
. In this case, the diffusible substrate, enters the hydrogel, 
reacts and generates a product that causes a change within the hydrogel. In the exampled 
work of Guiseppi-Elie et al. 
[8]
, glucose oxidase was co-immobilized by physical 
entrapment along with insulin within a pH responsive p(HEMA-co-DMAEMA) 
hydrogel. The mesh size was designed, in the un-protonated state, to permit ready 
diffusion of glucose into the hydrogel with little diffusion of insulin out. The catalytic 
action of GOx acting upon glucose results in the generation of gluconic acid leading to 
protonation of the 3° amine of DMAEMA and further swelling of the hydrogel. The 
expanded hydrogel, through an enhanced diffusion coefficient, then released insulin. 
The final two immobilization techniques for bioresponsive hydrogels are binding 
and adsorption. In binding, one member of the binding pair, such as biotin or protein-G, 
is first covalently immobilized and serves to immobilize the recognition molecule such as 
strepavidin. These species serve as cross-linking agents and by competitive binding can 
swell or collapse the hydrogel 
[16, 135]
. Adsorption immobilization of biomacromolecules 
has been thoroughly investigated, and it has been found that important factors controlling 
adsorption and desorption are hydrophilic/hydrophobic and electrostatic interactions 
[128, 
136]
.  Recently, the adsorption immobilization of enzymes on silicon nanoparticles and the 
subsequent incorporation into hydrogels has been demonstrated.  Improved activity, 
reduced enzyme leaching and improved mechanical strength were shown 
[137]
. 
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1.3. Transduction Mechanisms and Response Types  
1.3.1. Swelling and Collapse 
Bioresponsive hydrogels may utilize swelling or collapse of the polymer network 
as a signal-transduction mechanism.  The process of swelling and collapse occurs through 
ion actuation or virtual crosslinks.  The two transduction mechanisms are discussed here 
and applications in bioresponsive hydrogel are given. 
Transduction in bioresponsive polymers occurs through the networks of highly 
hydrophilic monomer containing moieties such as ethers, thiols or hydroxyls and 
ionizable groups such as carboxyls and amines. The latter groups have individual pKa 
values which, depending on monomer composition and dissociation strength, will 
produce a net charge on the hydrogel. Net charge neutrality is maintained by balancing 
the hydrogel charge with counterions drawn from the solution. Increasing or decreasing 
concentration of ions leads to an electroosmotic pressure as well as a space charge layer 
that extends into the diffusion layer in solution. A hydrogel in solution will swell or 
collapse to reach an equilibrium point where the osmotic pressure force, which drives 
water into the hydrogel, is balanced by the mechanical retractile forces of the chemical 
bonds holding the matrix together. This balancing of osmotic and mechanical forces in a 
hydrogel matrix is similar to the deformation of a spring to which a force is applied 
[138-
140]
.  This process has been modeled using a FEM approaches which relates transport, 
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Equation (20), electrostatics, Equation (21), and chemo-mechanical deformation, 
Equations (22) ‒ (25)[141, 142].   
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   (       )   (             )  (21) 
          (     (  )  ) (22) 
     (      ) (23) 
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           (25) 
Where C as concentration of species i; Deff is the effective diffusivity; z is the ion valence; 
um is the ion mobility; F is Faraday’s constant; V is potential; R is a reaction term; ε0 and 
εr are the vacuum and relative permittivity’s of the ion, respectively; σ is the stress tensor; 
E is the elasticity tensor; u is the geometric strain; επ is the swelling strain; k is the 
swelling coefficient; π and π0 are the osmotic and initial differential osmotic pressures, 
respectively; R is the ideal gas constant; T is temperature; Cα and Cα
ref 
are the 
concentrations and reference concentration at the gel-solution boundary, respectively; f is 
the mechanical damping parameter; ρ is the mass density; and b is the volume forces.   
Equations (20) ‒ (25) have been combined and implemented in FEM models to predict 
swelling and collapse 
[143, 144]
; however, extensions of FEM models into bioresponsive 
hydrogels, where the swelling or collapse is triggered by a biological agent, are largely 
undeveloped.   
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To utilize ionic transduction in bioresponsive hydrogels the reaction between the 
biorecognition species and the biological agent must produce or transport ionically active 
species to the interstitial spaces of the hydrogel.  The ionic species alters the equilibrium 
in the system and induces the cascade of chemical, electrical, and mechanical phenomena 
resulting in swelling or collapse.  This has been exemplified by oxidoreductase 
[145, 146]
 
and hydrolase 
[24, 147]
  enzyme systems and endosomolytic release systems 
[148, 149]
.  Novel 
Figure 1-5:  Reaction scheme, equivalent electronic circuit, and true table for the AND 
gate for multisignal-response hydrogels as AND/OR logic gates 
[5]
. 
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applications for these types of bioresponsive hydrogels include fully integrated feedback 
control
[49]
 and multisignal-response hydrogels as AND/OR logic gates 
[5]
, Figure 1-5. 
Alternatively, reversible crosslinks can be used to swell or collapse a hydrogel in 
response to a biological agent.  Crosslinking in hydrogels effects hydration by increasing 
or decreasing the mechanical retractile force which is counter-balanced by osmotic 
pressure, thus causing swelling or collapse of the polymer network.  The effective 
crosslink density νe, can be related to swelling ratio by Equations (26) ‒ (28) 
[150]
. 
    (     ) 
(26) 
         
   
  
   
 (27) 
  
  
    
  
  
  
(28) 
Where τ is the compressive strength, G is the compressive modulus, R is the gas constant, 
T is temperature, α is the ratio of hydrogel thickness before and after swelling, V0 and V2 
are the volume fraction of the polymer network during formation and after hydration, 
respectively, and ρg and ρs are the densities of the dried and solvated hydrogels, 
respectively.  Use of crosslinking to control polymer swelling has been demonstrated 
with small molecule recognition binding 
[151]
, antigen-antibody binding
[150]
, 
complimentary DNA recognition 
[15]
, protein-ligand binding 
[152]
, and enzyme-substrate 
recognition binding 
[153]
.  Novel applications using hydrogel crosslinking to effect 
swelling include:  pulsatile protein release 
[154]
, AND/OR logic gate swelling response 
[155]
 and quantum-dot fluorescence for label free DNA detection 
[7]
. 
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1.3.2. Degradation 
Another response that has been leveraged in the application of bioresponsive 
hydrogels is the degradation of the polymer matrix in response to a biomediated stimulus. 
Here, degradation is differentiated from erosion in that erosion occurs via hydrolytically 
labile bonds such as ester, anhydride, or anhydride-co-imide bonds 
[156-158]
.  This is a 
passive process dependent on environmental parameters pH and temperature; therefore it 
will not be considered bioresponsive.  For further information on eroding polymers the 
reader is directed to Nair et. al 
[159]
. 
Degradation is the breakdown of the polymer matrix into monomers and smaller 
oligomeric chains.  The transduction process in degradation is the breakdown of the 
polymer backbone bonds resulting in the dissolution of the polymer network which 
occurs by enzymatic cleavage.  Enzymatically triggered degradation in drug delivery and 
tissue engineering allows for targeted, controlled degradation of the polymer. The 
triggered degradation of the polymer matrix is advantageous because the matrix can 
remain in its native state until it is exposed to a specific enzyme. Degradation rates can be 
controlled by varying concentrations of the enzymatically cleavable crosslinking 
substrate, altering the sequence to increase or decrease its enzymatic affinity or reactivity, 
or altering the morphology of the hydrogel matrix effecting enzyme access 
[131, 160]
.  
Degradation of bioresponsive hydrogels has been demonstrated by the triggered 
degradation of multilayer polyelectrolytes 
[161]
, enzyme mediated hydrolysis of 
polysaccharide chains 
[162]
 and amide bond cleavage in peptides 
[163, 164]
.  Novel 
applications of degrading bioresponsive hydrogels have been demonstrated by in situ 
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polymerizing-degrading 
[6]
 hydrogels, Figure 1-6, and sensor-cell triggered, ruptured-
release of protein therapeutics 
[165]
. 
1.3.3. Release 
Release in bioresponsive hydrogels is considered a response and has been used 
extensively as a vehicle for the delivery of therapeutic molecules.  Biological triggers for 
release include redox potential 
[166]
, activity of biomacromolecules 
[24]
, or concentration 
of metabolites 
[16]
.  The transduction mechanisms for release are swelling or collapse of 
the polymer network through ionic actuation or degradation 
[24, 167]
 or the cleavage of 
Figure 1-6:  A bioresponsive hydrogel which gels in situ and degrades when exposed to 
collagenase
[6]
. (A) Wet weight of non-degradable and degradable hydrogels exposed to 
collagenase.  (B)  Wet weight of degrading hydrogels of varying degradable cross-linker 
concentration.  (C)  Amino acid modified PEG-amine hydrogel.  (D)  Collegenase 
cleavable cross linker.  (E)    Cell adherence peptide incorporated into PEG-succinimidyl 
hydrogel.   
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biologically active pendant groups 
[9, 163]
.  Using bioresponsive hydrogels as triggered 
release vehicles allows for tighter control over the amount of drug being delivered, the 
rate at which it is administered and can reduce unwanted side effects to ancillary systems 
because the drug is localized only to desired regions and release is motivated by the 
activity of a biomarker.  Wilson et al. demonstrated enzyme actuated release through the 
creation of a hydrogel-enzyme construct and explored covalent attachment loading and 
controlled release rate though varying crosslink density 
[9]
. The authors stoichiometrically 
controlled the loading of a peptide-linked chromogen by varying the mole fraction of the 
pendant, conjugatable amine group of co-polymerized 2-aminoethyl methacrylate 
(AEMA). Release of the chromophore was mediated by exposure to chymotrypsin which 
cleaved the covalently attached peptide. The release rate was controlled by changing the 
cross-linker concentration, and in effect, the apparent diffusivity of chymotrypsin 
[168]
.  In 
work by Lee et al., a virus mimetic nanogel was synthesized wherein targeting of tumor 
cells, which overexpress surface folate receptors 
[169]
, was achieved by surface modifying 
a bovine serum albumin-polyethylene glycol (BSA-PEG) shell and poly(L-histidine-co-
phenylalanine) core nanogels with folate ligands.  After undergoing endocytosis the pH 
responsive core would swell under endosomal pH and concomitantly release entrapped 
doxorubicin and escape to the cytosol by disrupting the endosome membrane through the 
proton buffering effect 
[149]
.  
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1.3.4. Mechanical Release 
1.3.4.1. Gelation 
In situ gelation has become an emerging trend in the application and research of 
bioresponsive hydrogels. Hydrogels that can cross-link in vivo following injection are 
desirable because they can be implanted as solutions using a syringe and they can 
negotiate close-fitting, tissue-to-gel contact in comparison to precast hydrogels. 
Physically crosslinking and photo-crosslinking approaches have been demonstrated; 
however, they have drawbacks such as low mechanical strength and the need for 
cytotoxic photo-initiators, respectively. An alternative approach being explored is 
enzyme mediated cross-linking of hydrogels 
[12, 170]
. The gelation of such hydrogels 
occurs by the linking of pendant groups through enzymes such as horseradish 
peroxidase
[171]
, phosphopantetheinyl transferase 
[172]
, or tissue transglutaminase 
[173]
. 
Gelation rate was shown to be dependent on the ratio of enzyme to bioactive species 
[12]
.  
Hughes et al. have demonstrated gelation by self-assembly of dipeptide fibers and sheets 
through enzyme mediated amide condensation of FMOC functionalized amino acids.  
Morphology, mechanical properties, and yield were shown to be a function of amino acid 
side groups 
[174]
.  For further discussion of in situ hydrogel formation, the reader is 
directed to Van Tomme 
[175]
.  
1.3.4.2. Shape Transformation 
The shape of a hydrogel construct is known to effect drug carrier performance 
[176]
. Engineering the ability to biologically trigger a shape change of a bioresponsive 
hydrogel is of growing interest. As an example, spherical and elliptical hydrogels 
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experience different hydrodynamic forces as they move through the vasculature. 
Additionally, elliptical hydrogels have been shown to avoid phagocytosis more readily 
than spherical hydrogels. While elliptical hydrogels are not phagocytosed as readily, they 
also do not undergo endocytosis at the targeted cell as readily as spherical gels. This 
makes it desirable to have an elliptical hydrogel in the vasculature, and then have a 
spherical hydrogel near the delivery site 
[177]
.  To this end, bioresponsive hydrogels which 
can change shape upon a tissue specific stimulus are being explored. In one construct, a 
shape transformational hydrogel was created which changes from elliptical to spherical 
orientation in response to pH, temperature and an analyte.  The shape change is driven by 
the balance of interfacial tension and polymer viscosity, Figure 1-7 
[3]
.  
1.3.5. Optical Response 
Bioresponsive hydrogels that exhibit an optical response to a stimulus are gaining 
traction as a viable platform for biodetection and biosensing. The mechanism for 
Figure 1-7:  Temperature, pH, and chemically responsive hydrogel which changes shape 
from an elliptical to a spherical configuration based on environmental conditions 
[3]
. 
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detection or sensing may result from swelling or collapse of the hydrogel matrix that 
changes the shape of a lens 
[178]
, changes the refractive index
[179]
, gelation 
[180]
, turbidity, 
or induces a change in absorption or emission 
[181]
. In each case the change in the 
hydrogel matrix causes a detectable or measurable optical response. Additionally, 
chromophores or fluorophores may be released pursuant to binding or become activated 
by catalysis 
[9, 18, 182]
. Responses can be visible by the naked eye or may require 
measurements of absorbance or emission at specific wavelengths 
[34, 180]
. In a more 
recently developed system, thioglycolic-acid-capped quantum dots (CdSe QDs) were 
covalently attached to an acrylamide based hydrogel microspheres that were cross-linked 
with DNA motifs. When exposed to the complimentary strand of targeted DNA, the 
binding of the DNA strands resulted in hydrogel collapse due to the uptake of 
counterions.  The collapsing event resulted in a blue shift in the Bragg diffraction peak.  
This system proved to be highly sensitive, down to 1 nM, and could differentiate DNA 
Figure 1-8: DNA sensing bioresponsive, quantum dot loaded hydrogel which elicits a 
shift in its peak absorbance upon exposure to the complimentary target DNA 
[7]
. 
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sequences that differed by one base pair, Figure 1-8 
[7]
.  
1.3.6. Electrochemical Response 
Due to their high biocompatibility, hydrogels have been widely used in 
biosensors, both as an interface between tissue and electrode and also as a host for 
bioactive molecules
[134]
.  By incorporating oxidoreductase enzymes into the polymer 
matrix, the biospecificity of the enzyme is conferred to the transducer, and the enzyme is 
stabilized in a hydrated 3-D milieu
[183]
. In amperometric biosensors, the electrodes act as 
an eventual source or sink for the electrons being transferred by the enzyme.  Biosensors 
which measure analyte concentrations have been designed based on other electrical 
properties such as potential or impedance 
[35]
. To increase sensitivity, reduce interfacial 
impedance, reduce interference from endogenous and exogenous species and improve 
biocompatibility, electroconductive polymers such as polyaniline, polythiophene and 
polypyrrole, have been synthesized into the voids of the hydrogel matrices 
[35]
. The 
resulting electroconductive polymer hydrogel composites also show the potential for 
programmed release of loaded drugs under modest voltage stimulation.  This is 
particularly useful in the development of prosthetic electrodes for deep brain stimulation, 
intraocular implants and cochlear implants.  Another approach to facilitate electron 
transfer in biosensors is the conjugation of the redox enzyme to single-walled carbon 
nanotubes (SWNT).  Enzyme-SWNT conjugates have been shown to increase the peak 
current; additionally, graphene based biosensors are also being developed based on 
similar principles
[184, 185]
 and may be incorporated into hydrogels. These composite 
materials add new response modes to the bioresponsive hydrogels.  
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1.4. Conclusions 
Bioresponsive hydrogels are increasingly being studied because they are highly 
biospecific, and they exhibit controlled response that can be readily combined with 
biomolecular recognition. Moreover, there are many technological opportunities in 
targeted drug delivery, biosensors and regenerative medicine that motivate continued 
energetic pursuit of devices based on bioresponsive hydrogels.  The application of 
bioresponsive hydrogels is wide ranging, and they have been developed into tissue 
engineering constructs, biosensors and targeted drug delivery vehicles.  Further 
development of drug delivery devices can be achieved by engineering a system which not 
only senses and responds, but couples the response to the triggering cue.  Coupling the 
response and trigger creates a molecular control loop, commonly seen in highly tuned 
metabolic pathways, capable of actuating activity levels of a biological moiety to a 
desired level.  The use of these materials will continue to expand as they become coupled 
and integrated with new technologies. 
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CHAPTER TWO 
2. TEMPERATURE DEPENDENT RELEASE MECHANISM OF MONO- AND DI-
VALENT IONS FROM PHOSPHORYLCHOLINE GROUP BEARING 
HYDROGELS  
2.1. Introduction 
Highly hydratable cross-linked polymers, or hydrogels, have become a mainstay 
in biological and biomedical applications 
[186]
 due to their desirable properties engendered 
by controllable high degree of hydration
[187, 188]
, cell and tissue biocompatibility 
[189]
 and 
high potential for molecular engineering 
[190]
 relative to other materials. A canonical 
example of a hydrogel, poly(2-hydroxyethyl methacrylate) (pHEMA), was first used in 
contact lenses for its optical clarity, dimensional stability, mechanical properties and 
biologically benign nature 
[191]
. Since then, hydrogels have expanded in molecular repeat 
unit composition, architecture and applications to have technological impact in drug and 
biomolecule theranostics 
[192]
, multiplexed biomolecular detection 
[192]
, biosensor-based 
molecular diagnostics 
[193]
, drug free macromolecular therapeutics 
[194]
, tissue engineering 
and regenerative medicine 
[195]
. Moreover, hydrogels are continually being molecularly 
engineered to serve as stimuli-responsive polymers 
[8]
 within their particular end-use 
environments by exploiting various sense and respond mechanisms 
[196-198]
. More 
recently, feedback control has been integrated into bioresponsive hydrogels creating 
synthetic analogs to tightly regulated metabolic pathways 
[199, 200]
. While development, 
application and commercialization of hydrogels moves forward, fundamental 
understanding of their properties, interactions between the local bio-environment and the 
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causal relationship between imbibed moieties and polymer structures are still an active 
area of research 
[197, 201]
. Controlled drug delivery is an area wherein fundamental 
understanding of hydrogel-drug interaction allows proper design of polymers and 
contributes to the successful development of drug delivery systems. The effects of 
hydrogel swelling dynamics; solute transport properties; in situ kinetics of enzymatic 
and/or binding recognition reactions; ionic interactions; and environmental (pH, 
temperature, ionic strength) changes can alter the performance of a biologically 
responsive system 
[198, 202-204]
. These factors greatly influence polymer design and could 
have unforeseen consequences on the release profiles of the delivered drugs, ultimately 
impacting safety and/or efficacy. 
Work done by Korseymer, Ritger and Peppas pioneered methods to study and 
model drug delivery from polymeric hydrogel systems 
[2, 205, 206]
. The culmination of this 
early work, using pHEMA as the drug delivery polymer, was the combination of two 
explicitly derived drug release models which describe diffusion controlled (Fickian or 
Case I) and polymer relaxation controlled (Case II) release; Equations (29) and (30), 
respectively. In general, polymeric hydrogels that do not exhibit appreciable relaxation or 
for which the polymer segmental relaxation time is much smaller than the characteristic 
diffusion time for solvent transport, experimentally display standard Fickian diffusion. In 
this case, solvent transport is controlled by a simple concentration gradient and water 
uptake by the polymeric hydrogel which exhibits the characteristic t
1/2 
dependence, with 
the resulting swelling also exhibiting t
1/2
 dependence, Equation (29). When hydrogel 
segmental relaxation is the dominant mechanism involved in solvent transport, then a 
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time-independent hydration is observed and the swelling will depend linearly with time t, 
Equation (30). Mathematically, these two release mechanisms have been shown to be a 
function of t
1/2
 and t (first order), for planar hydrogel geometries, which can be used to 
differentiate release mechanisms based on experimental observation. Previous work by 
Alfrey et al. showed Equations (29) and (30) could be summed to describe the transport 
of two species into a polymer matrix, one controlled through Fickian diffusion and one 
controlled through polymer relaxation-driven swelling, resulting in Equation (31) 
[207]
. 
Finally, the heuristic combination of terms in Equation (31) has resulted in a semi-
empirical mathematical description, Equation (32), which has been shown to accurately 
predict drug release profiles from planar, cylindrical and spherical geometries when 
    ⁄      . Additional utility of the model is gained since the value of the 
diffusional exponent, n, can indicate the predominant release mechanism; Fickian 
diffusion or polymer relaxation. The diffusional exponent has been shown to vary based 
on geometry and release mechanism as summarized in Table 2-1. 
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(32) 
Where, Mt is the concentration of the released drug in the bathing solution at time t, 
M∞ is the equilibrium concentration of the drug in the release solution, D is diffusion 
coefficient, l is slab thickness, k1 is the diffusional rate constant which is proportionally 
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related to D and l, k0 is the polymer relaxation constant, C0 is the initial concentration of 
the drug, k2 is the swelling rate constant which is proportionally related to C0 and l, kKP is 
the Korsmeyer-Peppas rate constant and   is the diffusional exponent.  
Table 2-1: Diffusional exponent values for various geometries and release mechanisms 
Slab Cylinder* Sphere Release Mechanism 
0.5 0.43 0.43 Fickian 
0.5 < n <1.0 0.43< n <0.89 0.43< n <0.85 Anomalous 
1.0 0.89 0.85 Case II 
*Indicates an aspect ratio of 2.25. Aspect ratio relation to n is provided in Appendix‒A, 
Figure‒2. Reprinted with permission from [2].   
 
In many cases, however, rate balanced Fickian diffusion and polymer relaxation 
or the presence of a third component that contributes to overall system dynamics; e.g. an 
analyte for a sensor or a drug molecule for release, can result in an intermediate type of 
transport mechanism, which is referred to as anomalous transport 
[208]
. To build upon 
previous work and expand the utility of the model developed by Korseymer, Ritger and 
Peppas, we 
[209, 210]
 and others 
[211]
 have been investigating the transport of charged 
species within hydrogels. Of particular interest is ion transport within pHEMA-based 
hydrogels containing biomimetic, zwitterionic moieties such as phosphorylcholine. 
Phosphorycholine, the polar head group of the outer leaflet of cell membranes, has 
emerged as a biomimetic moiety for conferring cyto-compatibility to hydrogels 
[212]
. The 
study of ion transport within such hydrogels under test conditions that emulate 
physiological conditions could potentially inform various pathologies associated with ion 
transport across biological membranes. Moreover, ion transport within hydrogels is 
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important in the design and application of wetting and disinfection agents for soft contact 
lenses, in controlling ocular drug delivery, in separation applications based on solute 
partitioning and in analytical techniques that employ hydrogel pre-concentration. Here 
the authors have investigated the effects of temperature, cation valence and swelling 
dynamics to determine the contribution of these factors to cation release kinetics.   
To investigate the effect of valence, monovalent (potassium) and divalent 
(calcium) cations were released from a phosphorylcholine containing p(HEMA)-based 
hydrogel matrices. Such electrostatic migration is aptly described by the Nernst-Planck 
equation, Equation  (33) 
[142]
.  Numerical solutions to the Nernst-Planck equation can be 
realized by coupling potential field effects through the Poisson equation, Equation (34) 
[142, 143]
.  While finite element modeling approaches have been successful in reproducing 
experimental results to simplified systems using these equation, explicit relationships 
have not been resolved for the coupled transport phenomena.  Experimental approaches 
are being taken to tease apart the importance of contributing phenomena to understand 
the role of charge density of the ion and hydrogel, the hydrodynamic radius of the ions 
involved, polymer relaxation dynamics and the molecular weight between crosslinks of 
the hydrogel that governs its mesh size.  
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Where Ci is the concentration of species i, Deff is the effective diffusivity, z is the 
valence of the ion, μ = FDeff/(RT) is the unsigned mobility, ψ is the electrical potential, v 
is the velocity of the solvent, ri is the reaction term, F is Faradays constant, ε0 is the 
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permittivity in free space, εr is the dielectric constant, Nf and Nb are the numbers mobile 
and bound species, respectively. 
To realize these distinctions, ions may be introduced into hydrogels during 
formulation alongside monomer and pre-polymer constituents prior to crosslinking (pre-
synthesis loading). Alternatively, ions may be introduced into hydrogels by partitioning 
into the fully-hydrated, equilibrium-swollen hydrogel (post-synthesis loading). In 
addition, the effect of temperature was investigated by monitoring ion release over a 
temperature range of 25-45°C. In this work a 3 mol % tetraethyleneglycol diacrylate 
(TEGDA) cross-linked biomimetic poly(2-hydroxyethyl methacrylate) (pHEMA)-based 
hydrogel was synthesized to contain 2-methacryloyloxyethyl phosphorylcholine (MPC) 
units (1 mol %) and poly(ethylene glycol) (400) monomethacrylate (PEG(400)MA) (5 
mol% ) cast into short cylindrical microforms. Both MPC and PEG constituents play a 
role in conferring biomimetic cyto-compatibility to the hydrogel 
[213, 214]
. The transport of 
monovalent potassium cations (K
+
) and divalent calcium cations (Ca
++
) was studied 
under two conditions. Firstly, ions in the form of the powdered chloride salt were loaded 
into the hydrogel during formulation and prior to UV crosslinking. Secondly, ions in the 
form of an aqueous solution of the chloride salt were partitioned into the blank hydrogel 
during equilibrium hydration of the previously synthesized microform. Temperature 
dependent release of ions was studied at 25, 31, 37 and 45
o
C using calibrated ion 
sensitive electrodes (ISEs).  
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2.2. Experimental Section 
2.2.1. Reagents 
Anhydrous calcium chloride (CaCl2, ≥99.99%) and potassium chloride (KCl, 
≥99.0%) were purchased from Sigma Aldrich (Milwaukee, WI, USA). The hydrogel 
components: HEMA, PEG(400)MA, the divalent cross linker, TEGDA, and the 
photoinitiator, 2,2-dimethoxy-2-phenylacetophenone (DMPA, 99%), were also purchased 
from Sigma Aldrich. The biomimetic reagent 2-methacryloyloxyethyl phosphorylcholine 
(MPC) was prepared elsewhere as previously described 
[215]
. The removal of 
polymerization inhibitors hydroquinone and monomethyl ether hydroquinone from the 
individual cocktail components proceeded by passing the liquid monomers over an 
inhibitor removal column. The buffer of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid sodium salt (HEPES) was prepared to physiologically relevant conditions (pH = 7.4; 
ionic strength = 160 mM) 
[216]
. HEPES buffer was firstly prepared to 100 mM and then 
titrated by the addition sodium hydroxide (NaOH) to a concentration of 50 mM. Finally, 
the ionic strength of the buffer was adjusted by the addition of sodium chloride (NaCl) to 
a concentration of 160 mM. Deionized (MilliQ DI, Billerica, MA, USA) water was used 
to prepare all of the solutions. 
2.2.2. Preparation of Monomer Cocktail and Synthesis of Hydrogel Disks 
Hydrogel pre-polymer cocktails were prepared by combining monomer 
constitutes in the mol % outlined in Table 2-2. To improve solubility, ethylene glycol and 
water were added to the mixture in a 1:1 (v/v) ratio such that the two species combined 
comprised 20 volume % of the formulation. After combining constitutes, the mixture was 
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ultrasonicated for 5 minutes and sparged with nitrogen to remove dissolved oxygen. 
Hydrogel discs were fabricated by placing silicone isolators (JTR12R-2.0, Grace Biolabs, 
Bend, OR, USA) onto trichloro(octadecyl)silane(OTS)-treated hydrophobic glass 
microscope slides and 31 µL of hydrogel pre-polymer was pipetted into the individual 
silicone isolation chambers and a second hydrophobic glass slide was placed on top of the 
silicone thereby sealing the liquid cocktail into the chambers between hydrophobic 
surfaces. The hydrogel-containing, sandwiched isolation chamber was immediately 
placed in a crosslinker (CX-2000, UVP, Upland, CA, USA) and UV irradiated at 366 nm 
for 10 min to initiate polymerization. The polymerized discs were then removed, 
retaining the form dimension of the chambers (thickness l = 2.0 mm and radius a = 2.25 
mm), and stored at 4°C until use. Figure 2-1A, B and C show a representation of the 
resulting macromolecular network structure, a hydrated hydrogel disc and the 
sandwiched silicon isolation chamber, respectively. 
Table 2-2:  Composition used in prepolymer formulation for ion release studies. 
Hydrogel Constituent Mol Percent of Hydrogel (%) 
HEMA 90.0 
TEGDA 3.0 
PEG(400)MA 5.0* 
MPC 1.0 
DMPA 1.0 
*Mol % calculated for repeat unit. 
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Loading of the hydrogel discs with the salt species, CaCl2 or KCl, proceeded 
through two methodologies. The first method, pre-loading, was achieved by dissolving 
the salts in the pre-polymer cocktail at a concentration of 100 mM. One pre-polymer mix 
was created for each salt.  Dissolution of the salt was achieved by ultrasonication for 10 
min followed by stirring overnight.  The second method, post-loading, proceeded by 
bathing the hydrogel disc in a 100 mM solution of the respective salt at the temperature 
of the release experiment. Hydrogel discs that were formulated to contain CaCl2 and KCl 
for the pre-loading experiments were used in subsequent post-loading experiments, after 
the pre-loading experiment had occurred, and were only bathed in salt solutions that 
contained their respective preloaded salt. To ensure the polymer achieved equilibrium 
with the loading solution, hydrated disc weight was monitored hourly until the weight 
stabilized which took 2-4 hours, typically. 
Figure 2-1:  Schematic of the molecular structure and mol% composition of the pre-
polymer constituents of poly(HEMA)-based hydrogel possessing MPC, PEG(400)MA 
and cross-linked with 3 mol% TEGDA. 
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2.2.3. Experimental Setup for Release of Charged Species 
Prior to release, a calibration curve for each ion selective electrode (ISE) (Cole-
Palmer ISE Electrode SC-27502-09 and YO-27504-26) was created by duplicate 
measurement of the voltage response to serial dilutions of CaCl2 or KCl in HEPES buffer 
at each temperature, Appendix‒A, Figure‒1. The calibration curve was used to convert 
voltage release data to concentration based on the Nernst equation. The voltage response 
from the ISE was collected using a Model DI-155 data acquisition interface (DATAQ 
Instruments, Inc., Akron, OH, USA) and associated software which recorded and ported 
the data to MS Excel. Release of the pre- or post-loaded Ca
++
 or K
+
 cations was initiated 
by placing the loaded disc into a temperature equilibrated scintillation vial containing 
3mL of HEPES buffer and the appropriate ISE. To ensure ideal sink conditions, the 
release volume (100 times the disc volume) was constantly stirred during release and 
maintained at a constant temperature. Release experiments were performed in replicates 
of 3-12 per experimental setup. 
2.2.4. Calibration and Performance of ISEs 
ISEs are convenient for this type of ion release study as they generally have 
excellent response times, are quite stable and may be readily interfaced to data 
acquisition systems. However, ISEs do have a narrow temperature performance window. 
Accordingly, each ISE used was calibrated at each of the several temperatures of this 
study. Appendix‒A, Figure‒1, shows the calibration curves obtained for duplicate runs 
over five decades of concentration at 25, 31, 37 and 45 °C. There is a clear linear trend of 
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increasing slope expected for the behavior of ISEs; however, the slopes obtained did not 
comport with the expected Nernst value.  
2.2.5. Hydrogel Characterization 
Gravimetric hydrogel characterization was performed to determine Swelling% and 
Degree of Hydration (DoH) of the hydrogels in HEPES buffer or HEPES buffer 
containing different concentrations of the salt KCl or CaCl2 between 25 and 45
o
C. To 
calculate Swelling%, Equation (35), the hydrogel discs were weighed on a microbalance 
in their hydrated (H) and dehydrated (D) states. Swelling%, were determined immediately 
before and immediately after release of ionic species at various temperatures by 
measuring the weight of the hydrogel disc at those times (Sb – before and Sa - after).  The 
difference in Swelling% as a result of the release was determined from the before and 
after measurements and was calculated using Equation (36). DoH was calculated using 
Equation (37). 
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Where MH is the weight of the hydrated hydrogel in HEPES buffer, MD is the 
weight of the dehydrated hydrogel and MS is the weight of the hydrogel immediately 
before (MSb) or immediately after (MSa) release of the ionic species.  
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2.2.6. Analysis of Release Profiles 
It was previously shown that release of Ca
++
 and K
+
 ions from TEGDA cross-
linked p(HEMA)-based hydrogel containing phosphorylcholine groups was best 
represented by the Korsmeyer-Peppas model 
[209]
. Accordingly, nonlinear least squared 
(NLLS) fits to Equation (32) were performed for all release profiles obtained. Data fitting 
used the portion of the release curve where     ⁄      . Statistical analysis was 
performed using Matlab (2012a) to determine statistical difference of parameters kKP and 
n for loading, ion type and temperature groups. The analysis used a nested ANOVA 
approach with temperature as a nested, random variable and ion type and loading method 
as the main, fixed variables. The nested design is provided in Appendix‒A, Table‒1. 
Tukey HSD was used to determine if composite values of n were statistically different 
from each other and a multi-comparison test with the Bonferroni correction was used to 
determine if they were different from their theoretical values. Regression analysis was 
performed using MS Excel Data Analysis Tool Pack. 
2.3. Results and Discussion 
2.3.1. Release Profiles 
Figure 2-2A-D show the normalized release profiles of calcium and potassium 
ions from pre-loaded and post-loaded hydrogels into pH 7.4 HEPES buffer at 25, 31, 37 
and 45 °C. The molar concentration of the appropriate ion in the release solution at a 
given time, Mt, was determined from the acquired voltage vs. time data by use of the 
experimentally prepared calibration curves. The Mt value was normalized to the 
equilibrium ion concentration in the release solution, M∞, and plotted as a function of 
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time for each temperature studied. Normalization was used to eliminate release 
dependence on the initial ion concentration in the hydrogel disc and for fitting to 
Equation (32).  Visible from the release profiles, it is apparent that calcium exhibits a 
much faster release than potassium from pre- and post-loaded hydrogels.  The subsequent 
discussion seeks to illuminate possible reasons for the observed phenomena, such as 
different mechanisms of release. 
Figure 2-2:  Normalized release profiles of pre- (A&C) and post- (B&D) loaded Ca++ 
(A&B) and K+ (C&D) ions from pHEMA hydrogel disks. 
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2.3.2. Cation Effects on Release and Polymer Structure 
The non-linear least squared fit of the release profiles with Equation (32) 
generated constants, n and kKP, which were subsequently analyzed to determine the effect 
of cation valence on the release profiles. Composite values of the diffusional exponent, n, 
and the release rate constant, kKP, were calculated for K
+
 pre-loaded, K
+
 post-loaded, Ca
++
 
pre-loaded and Ca
++
 post-loaded gels.   Figure 2-3A shows the results of these 
calculations where values of n for K
+
 (blue bars) are clearly at or below the threshold for 
Fickian transport and values of n for Ca
++
 (red bars) are clearly Case II and anomalous 
transport. To reinforce these graphically obvious findings, a multiple comparison (Tukey 
HSD) test was performed to determine statistical difference between the groups. At 95% 
confidence, it was shown that there was no statistical difference in the diffusional 
exponents for pre- vs. post-loaded hydrogels when potassium was the released ion while 
there was a statistical difference when calcium was the released ion (p >0.05). 
Additionally, it was shown that values of n for K
+
 and Ca
++
 were statistically significantly 
different in both the pre- and post-loaded cases (p <0.05). This indicates that cation 
valence clearly has a significant effect on the mechanism of release. A second multi-
comparison (LSD with a Bonferroni correction) test showed that values of n for pre-
loaded K
+
 were not statistically different than 0.43 indicating that the hydrogels 
containing K
+
 exhibited release profiles predicted by Fickian diffusion. Additionally, 
post-loaded K
+
 release profiles resulted in values of n that were statistically lower than 
the Fickian value of n = 0.43.  For post-loaded Ca
++
 the diffusional exponent was not 
statistically different that 0.89 indicating the hydrogels with post-loaded Ca
++
 exhibited 
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release profiles that were consistent with a Case II type release behavior. Finally, the 
hydrogels possessing pre-loaded Ca
++
 had n values that were found to fall between 0.43 
and 0.89 indicating anomalous release behavior.  An alternate statistical analysis 
accounting for subsampling, nested ANOVA, supported these findings, Table 2-3. 
Table 2-3: Nested ANOVA for the effect of loading method, ion type and temperature on 
n and kKP. 
Nested ANOVA for Diffusional Exponent (n) 
Source SS d.f. MS F P 
Loading 0.2371 1 0.2371 3.12 0.0970 
Ion 3.1399 1 3.1399 41.28 0.0000 
Temp(Loading,Ion) 1.0551 13 0.0812 1.74 0.0634 
Error 4.5592 98 0.0465     
Total 8.7794 113       
Nested ANOVA for rate constat (kKP) 
Source SS d.f. MS F P 
Loading 0.0012 1 0.0012 0.18 0.6739 
Ion 0.1763 1 0.1763 28.23 0.0001 
Temp(Loading,Ion) 0.0892 13 0.0069 2.6 0.0038 
Error 0.2583 98 0.0026     
Total 0.5187 113       
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Figure 2-3:  (A) Composite diffusional exponent, n, values for different ion and loading.  
Where * indicates statistical significance (p<0.05), ‡ indicates not statistically different 
than Fickian value of n (0.43) and † indicates not statistically different than Case II value 
of n (0.89).  (B) Composite rate constant, kKP, value for various ion and loading.  Shaded 
region indicated range of kKP values found elsewhere for water transport in hydrogels 
[4]
.  
(C) Diffusional exponent values for hydrogels which do not (empty) and do (filled) 
contain MPC.  
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The dependence of n on ion valence suggests that the interaction between the 
mono- or di-valent ions and the zwitterion containing polymer are quite different, and this 
interaction influences not just the release profile but the release mechanism. The 
interactions between the ions and polymer which affect the release profile may be 
understood with polymer swelling theory and polymer dynamics.  The theory, developed 
by Flory and Huggins, originally described environmental effects of entropic polymer 
relaxation (rubber elasticity theory)
[80, 217]
 and free-energy dependent swelling 
(equilibrium solvation theory)
[97]
; however, it has been extended to include cationic, 
anionic and pH sensitive hydrogels 
[218]
.  The free energy of the system, ΔG, can be 
expressed as a function of the free energy of elastic deformation, ΔGel, polymer-solvent 
mixing, ΔGmix, and ionic contributions, ΔGion, Equation (38).  Furthermore, the osmotic 
swelling pressure of a swollen polyelectrolyte gel, which is equal to the osmotic pressure 
of the solution at equilibrium, may be written as a function of the pressure contribution of 
these terms, Equation (39) 
[219, 220]
 .  
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Where R is the ideal gas constant, T is temperature, V1 is the molar volume of the 
solvent, φ is the volume fraction of the polymer, χ is Flory-Huggins interaction 
parameter, A is a constant of order unity, v is the concentration of network chains, i is the 
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fraction of charged monomers, Vm is molar volume of the monomer and cgel and csol are 
the concentrations of added salt in the gel and solution at equilibrium, respectively. 
Work by Horkay et al. 
[220]
 used this theory to demonstrate the interaction of an 
anionic polyelectrolyte hydrogel, sodium poly-acrylate cross-linked with N,N′-
methylenebis(acrylamide), with alkaline metal salts (LiCl, NaCl, KCl, and CsCl), 
alkaline earth metal salts (CaCl2, SrCl2, and BaCl2) and rare earth metal salts (LaCl3 and 
CeCl3). The key findings of their work, applicable to ion release from zwitterionic 
hydrogels, were; i) that the alkaline and alkaline earth metals do not contribute to the free 
energy of elastic deformation; subsequently, it was proposed that neither strongly interact 
to form cross-links with anionic pendent groups of the polymer.  ii) Through first and 
second order Flory-Huggins interactions parameters, it was shown that the alkaline 
metals do not contribute to the free energy of mixing, ΔGmix, while the alkaline earth 
metals do contribute to this parameter. The entropically driven ion exchange between the 
polymer and different classes of aqueous solvated metal ions has been observed by others 
[221]
, explained by the higher valence number of the alkaline earth metals as this allows 
them to interact more strongly with negatively charged moieties on the polymer 
backbone, relative to alkaline metals.  The alkaline metals do not contribute to polymer-
solvent interactions, and conversely, alkaline earth metals form polymer-ion complexes 
through charge-charge interactions between the divalent cations and the anionic 
polyelectrolyte. Studies of the sulfobetine containing polymer, poly(N/N-dimethyl 
(methacryloyloxyethyl) ammonium propane sulfonate) and sulfobetine brushes 
[222-224]
 
likewise show the independence of monovalent cation action. Similar observations were 
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made for the swelling behavior of poly(MPC) that had been immersed in Li
+
, Na
+
, K
+
, 
Ca
++
, Mg
++
 and NH4
+
 as the chloride salt. 
[225]
.  While physical properties, such as charge 
density and hydrodynamic radius, differ, the primary cause of the polyplex formation is 
determined by the valence of the ion 
[209, 220]
 
Diffusional exponent values reported here are consistent with the findings by 
Horkay et al. 
[220]
. In both cases, hydrogels produce release profiles for K
+
 ions reflective 
of Fickian diffusion and which are expected for non-interacting entities being released 
from a hydrogel. On the other hand, Ca
++
 release profiles demonstrate Case II or 
Anomalous release, apparent by the t
1
 dependent release profiles, suggesting the 
influence of relaxation of ion-polymer complexes must occur for divalent cation release. 
Further evidence for this hypothesis is found from an investigation of the hydrogel degree 
of hydration. The DoH, which is related to φ, is presented as a function of the bathing salt 
concentration in HEPES, Figure 2-4. Hydrogels bathing in both KCl and CaCl2 solutions 
exhibited salt concentration dependent reduction in DoH; however, hydrogels in the KCl 
solution retain more water than the gels in CaCl2 as salt concentration was increased. The 
decrease in DoH for gels in KCl solution can be explained by the osmotic pressure of the 
salt, represented by the term Πion in Equation (39).  Hydrogels in CaCl2 solutions show a 
greater decrease in DoH as a function of salt concentration since swelling of the gels is 
affected by Πmix in addition to Πion. 
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To investigate the possibility of an interaction between either of the two 
respective mono- and di-valent ions, potassium or calcium, and the zwitterionic MPC 
groups, pre-loaded hydrogels were formulated which did not contain MPC (0 mol % 
MPC) and the diffusional exponents were determined from their release profiles as 
previously described. A comparison of the n values obtained from hydrogels containing 0 
mol% MPC and 1 mol% MPC is shown in Figure 2-3B. When the same ion was tested, 
there was no statistically significant difference between the values of n for hydrogels 
which contained 0 mol% MPC (empty bars) and 1 mol% MPC (filled bars). An 
examination of the diffusional exponents across cation valance but within the same 
polymer formulation revealed a statistically significant difference. The transport 
exponents for release from hydrogels which contained 1 mol% MPC but had different 
ions loaded into the polymer were significantly different. That is, the mechanism of 
release of K
+
 and Ca
++
 from 1 mol% MPC containing hydrogels was convincingly 
different. The K
+
 ions were released by a Fickian transport mechanism while the Ca
++
 
ions were released by an Anomalous or Case II transport mechanism. Finally, a similar 
Figure 2-4: Degree of hydration for hydrogels as a function of the bathing solution salt 
concentration and temperature.  
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comparison was made for 0 mol% MPC hydrogels with the two different ions. In this 
case statistically significance difference in the transport exponents was not shown. This 
indicates that both the presence of MPC and the valence difference between the two ions 
was required in order to establish a different release mechanism in pre-load hydrogels. It 
is believed that the presence of the Ca
++
 ions facilitates the formation of the PC based 
polyplexes 
[226]
. 
As with the diffusional exponent, n, the rate constant, kKP, was shown to be 
significantly different for ion valence (p value < 0.05) but not for loading methods, 
Figure 2-3C. That is, the loading method did not appear to alter the mechanism of release. 
The values for kKP do not fall within a range of values, 0.0028 - 0.0332 (s
-n
), reported 
elsewhere for the transport of H2O into pHEMA-based hydrogels at pH 7.0 
[4]
. In the 
cited study, the diffusional exponent was found to range from 0.369 - 0.556, indicative of 
a Fickian diffusion release mechanism. The comparison of the rate constants of between 
H2O and K
+
 is of particular interest since the normalized released profiles are both linear 
with respect to t
1/2
 but produce drastically different rate constants. A potential explanation 
for higher kKP values for charged vs. neutral species may be found in the electromigration 
term. Currently, electromigratory effects under the influence of the ζ-potential of the 
microform, have not been put into the mathematical context of Equation (32), so behavior 
of n or kKP via gradient potential release is not available; however, if diffusion and 
electromigration have similar theoretical transport exponents, the rate constants would 
become additive, Equation (40). 
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 (     ) 
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(40) 
Where kF and kE are the rate constants for Fickian diffusion and electromigration, 
respectively. The higher values of kKP for K
+
 relative to H2O could be explained by the 
additional driving force of electromigration if these effects are additive. Ca
++
 has a value 
of kKP between K
+
 and H2O. Since Ca
++
 release mechanism is Case II or Anomalous, the 
contribution of electromigration to kKP may be attenuated as it follows a t
1
 rather than a 
t
1/2
 dependence.  For electromigration to occur, a potential driving force must exist in the 
system.  Three possible sources of a field are hypothesized to be:  i) shielding of 
negatively charged groups on the hydrogel resulting in increased positively charged 
groups which would electrostatically repel positive ions (pKa PC = 7.2 
[227]
); ii) charge 
separation between positive and negative ions due to different effective diffusivities 
resulting in temporal potential gradients; iii) difference in charge distribution across the 
hydrogel-solution interface. It is unclear if the different kKP values are caused by the 
contribution of an electromigratory effect or other factors, such as polymer composition. 
Further mathematical relations and experimental work will need to be explored to 
investigate the effects of electromigration on the rate constant of release. 
2.3.3. Temperature Effects on Release 
Figure 2-5A shows the diffusional exponent as a function of temperature for both 
cation type and loading method. Temperature dependence of n suggests the mechanism 
of release is thermally activated while temperature independence suggests the mechanism 
of release is not thermally activated over the temperature range studied. For hydrogels 
 56 
 
that were pre- or post-loaded with K
+
, a temperature independence, determined by 
regression analysis of the slope (p>0.05), of n values was observed suggesting the 
mechanism of release is consistently Fickian over the temperature range. Temperature 
dependence of n values is observed for Ca
++
 pre-loaded hydrogels (p<0.05) which 
explains the previously discussed anomalous value of n reported for the composite of the 
values, Figure 2-3A. The value of the diffusional exponent for Ca
++
 pre-loaded hydrogels 
is Anomalous at low temperatures (25 and 31
o
C) and moves towards a Fickian value for 
higher temperatures, 37 and 45
o
C. This suggests that at lower temperatures there is not 
enough thermal energy to disrupt the cation and polyelectrolyte complexes. Placing the 
hydrogel disc into the buffered solution increases the chemical potential difference 
between the cation and its surrounding environment; subsequently, the complexation sites 
are relaxed releasing the cation into void spaces within the hydrogel where it then 
diffuses out. An increase in temperature correspondingly increases the thermal energy of 
the cation-polyelectrolyte complexes, at high enough temperatures; the thermal energy 
will be enough to disrupt this interaction. This will create solvated Ca
++
 cations that are 
not hindered by the PC polyplexes and therefore readily diffuse out producing a Fickian 
release profile. Notably, pre-loaded Ca
++
 was released more quickly at low temperatures 
than at high temperatures.  While the decreasing n value suggests the opposite to occur, 
decreasing kKP values also contribute to the predicted profiles and can account for this 
discrepancy. 
The release of Ca
++
 that were post-loaded into hydrogels exhibit temperature 
independence (p>0.05) and exhibit n values consistent with Case II transport over the 
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temperature range. Since the post-loading occurred through partitioning, it is possible that 
the majority of the loaded Ca
++
 was incorporated into the hydrogel through complexation; 
conversely, the pre-loaded hydrogels did form substantial aggregation sites since the 
polymer chains and Ca
++
 ions may have restricted mobility in the low hydration state of 
the polymer immediately following polymerization. This would reduce the number of 
complexation sites being relaxed during release and increase the amount of free Ca
++
 
available for release though a hindered-Fickian mechanism.  
Temperature dependence of kKP was investigated through analysis of Arrhenius 
plots. Figure 2-5B shows a decrease in the value of kKP with increasing temperature for 
K
+
 release while the value of kKP remains constant with temperature for Ca
++
 release 
[209]
. 
The unaltered kKP values were used in the Arrhenius plots. Apparent activation energies 
for release of K
+
 and Ca
++
 were determined from the slope of the Arrhenius plots, Figure 
2-5C, and were calculated to be -19±15 and -17±20 kJ/mol, respectively.  
Regression analysis of ln(kKP) vs. Temperature
-1
 showed the slope for potassium 
was statistically different than zero (p < 0.05) while the slope for calcium was not 
statistically significantly different than zero (p > 0.05). This indicates that the calcium 
release does not exhibit temperature dependence over the temperature range investigated 
while potassium release does display temperature dependence over the same range. The 
decreasing kKP values vs. temperature and the negative activation energy are of interest 
as, it is known that diffusivity, calculated to be 2.03×10
-5
 and 3.90×10
-6
 cm
2
/s using 
Equation  (41) for pre-loaded potassium and calcium, respectively, 
[228]
 and mobility of 
charge carriers increase exponentially with temperature 
[229]
. The source of the negative 
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apparent activation energy is currently unclear; however, complexities arising from ion 
transport within the hydrogel may contribute to the phenomena. One potential complexity 
that could explain the negative activation energy is offered by consideration of polymer 
swelling as a function of temperature. Figure 2-4 shows temperature dependence in the 
DoH for hydrogels bathing in KCl and CaCl2 salts. While the dependence appears non-
linear, hydrogels at 37 and 45
o
C demonstrated a lower DoH than gels at 25
o
C. Invoking a 
porous media model of transport, Equation (42), it is clear that Deff is a function of DoH 
through void fraction, Equation (43) 
[198]
. Since DoH of the hydrogel decreased as 
function of temperature, the effective diffusivities will correspondingly decrease which 
would result in a negative apparent activation energy.  This consideration is clearer for 
K
+
 as it follows Fickian release; however, Ca
++
 has additional effects of polymer 
interactions and subsequently is a more complex system which may explain the 
difference in the temperature dependence of the two ions.  Trongsatitkul et al. observed 
similar negative activation energies for FITC-dextran release from PNIPAm and 
contributed the phenomena to a denser polymer at higher temperatures, similar to the 
explanation provided here, and adsorption/desorption processes which competed with 
Fickian diffusion for the available kinetic energy to activate the processes 
[230]
. 
 
        (
   
 
)
  ⁄
 (41) 
            
 
 
 
(42) 
      (       ⁄ )  (43) 
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Where Kp is the portioning coefficient, KR is the reflection coefficient, D0 is the 
diffusivity in buffer, ε is polymer void fraction, τ is the tortuosity and ρHG and ρsol are the 
densities of the hydrogel and solution, respectively, and n = 0.43. For ion transport, in 
order to maintain electro-neutrality within the hydrogel, as the ions are transported out of 
the hydrogel, their counter anions must simultaneously electromigrate. Since calcium is a 
divalent cation, twice as many counter anions must simultaneously electromigrate. This is 
in contrast to only one counter anion for the electromigration of potassium. While is this 
simplified view, which may be justified in water and below the dilute solution limit, this 
model is rendered complicated by; i) the distribution of appropriate voids within the 
hydrogel, ii) the solvating influences of free and bound water within the hydrogel, iii) the 
number, distribution and nano-architecture adopted by the charged moieties associated 
with the zwitterionic pendant groups of hydrogel and iv) the membrane potential gradient 
across the polymer–buffer interface. Since multiple processes may be contributing to 
these apparent activation energies more complex model may be needed to interpret the 
values. 
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Figure 2-5: (A) Diffusional exponent, n, as a function of temperature.  (B)  Rate constant, 
kKP as a function of temperature.  (C) Arrhenius plots of kKP for potassium and calcium, 
respectively. 
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2.3.4. Hydrogel Swelling and its Effects 
Theory resulting in Equation (32), allows experimental determination of release 
mechanism from hydrogel matrices by examination of the diffusional exponent. The 
degree of polymer swelling which occurs during release, ΔSwelling%, was measured at 
temperatures 25 and 37
o
C, as shown in Figure 2-6.  For both ions it was found that an 
appreciable change, Δ = 16 to 23%, in Swelling% occurred for the preloaded hydrogels. 
This is expected as the preloaded discs begin in an un-hydrated state and subsequently are 
further away from equilibrium. Conversely, the post-loaded hydrogels demonstrated a 
minimal ΔSwelling%, Δ = -8 to -2%, with only one, calcium at 25oC, having a 
statistically significant change (p < 0.05) in Swelling% during the release. Interestingly, a 
reduction in the Swelling% was observed for the post-loaded discs, which was 
unexpected since as t→∞, Swelling%→100%. The cause of this initial reduction is 
unknown; however, it is hypothesized that it may be due to the weight loss of the salts 
within the polymer matrix. Further experimentation needs to be performed to test this 
conjecture. 
Statistical analysis of the composite values showed no difference between the 
diffusional exponents for pre- and post-loading methods when potassium was the 
released ion. Since K
+
 release was shown to be unaffected by polymer relaxation, this 
result is expected. For Ca
++ 
release, which did demonstrate polymer relaxation effects, 
interpretation of the diffusional exponent for pre- and post-loading can be used to glean 
insight to the relation between polymer swelling and relaxation. If n values were reduced 
for the post-loaded relative to the pre-loaded, it would have indicated the removal of 
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polymer swelling phenomena removed the polymer relaxation effects on the release 
mechanism. Since this did not occur and the n values for post-loaded Ca
++
 release 
exhibited values predicted by Case II type release, it is concluded that polymer relaxation 
and polymer swelling are two independent processes and only the former effects ion 
release. During polymer relaxation, polymer pendent groups reorganize to reduce 
mechanical strain and relieve complexation sites while in polymer swelling the 
mesoscopic structure of the polymer is changing to accommodate a high water content to 
balance osmotic and mechanical forces. The latter happens on a time scale much longer 
than ion release and subsequently does not play a contributing role in the release 
mechanism.  
 
 
Figure 2-6:  K
+
 and Ca
++
 releasing hydrogels’ ΔSwelling% for pre- and post-loaded 
release.  
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2.4. Conclusions 
In this work the release profiles of K
+
 and Ca
++
 from zwitterionic, pHEMA based 
hydrogels were studied. The contribution of polymer relaxation, valence state and 
temperature to the diffusional exponent and rate constant were investigated. It was shown 
that ion charge played the most significant role in the mechanism of release. This is 
primarily caused by a weak interaction between divalent cations and polyelectrolyte 
anions forming polymer-ion complexation sites which govern release.  This interaction is 
not observed for monovalent ions and subsequently the mechanism of release is different.  
Moreover, it is shown that the presence of both MPC and a divalent cation is necessary to 
experimentally observe the interaction.  Temperature dependence of the diffusional 
exponent was observed for calcium but not potassium. This is likely due to a transition 
between case II type and Fickian type release for calcium. The cause for the transition is 
the increase of thermal energy which disrupts the polymer-ion complex. It was 
additionally shown that K
+
 diffusivity constants followed Arrhenius type activation with 
apparent activation energy of -19±15 kJ/mol. Conversely, kKP for Ca
++
 did not 
demonstrate a temperature dependent relation. The apparent negative activation energy is 
not fully understood by, but it is not due to diffusion or ion mobility. Temperature 
dependent polymer swelling is a proposed hypothesis for the negative apparent activation 
energy. Statistical analysis showed differences in the release rate constant for each ion. 
The observed values are much higher than for neutral molecules, and it is proposed that 
the increase is primarily due to electromigration. This work demonstrates the Korseymer-
Peppas release equation is an adequate model for the prediction of ion release from 
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zwitterionic hydrogels; however, the work has shown other factors such as 
electromigration may play a role in ion release from hydrogels.  Mechanistic phenomena 
were investigated through the diffusional exponent further demonstrating the utility of the 
equation. While fundamental phenomena of ion release from hydrogels has been 
elucidated here, further mathematical and experimental investigation of this system will 
be required to produce a more complete theory involving electromigratory effects. 
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CHAPTER THREE 
3. TARGETING HOMEOSTASIS IN DRUG DELIVERY USING BIORESPONSIVE 
HYDROGEL MICROFORMS 
3.1. Introduction  
Hydrogels are polymers synthesized from highly hydrophilic monomers and/or 
pre-polymers into networks that imbibe large amounts of water, are passively 
biocompatible due to their favorable interaction with extracellular matrix (ECM) proteins 
and are highly versatile in their range of possible biotechnical applications that exploit 
their swelling and de-swelling dynamics 
[186]
. Because of these characteristics, hydrogels 
have been extensively studied for a wide range of biomedical applications that include 
controlled drug delivery 
[202, 231, 232]
, tissue engineering and regenerative medicine 
[29, 233]
 
and diagnostic biomedical biosensors 
[234-236]
.  Hydrogels have also evolved over the 
years through several generations wherein increased conferred functionality, control of 
polymer architecture and improved processing has enabled new and innovative 
applications resulting in the moniker of “smart materials”. Among these smart 
applications is one wherein the ability to sense and react with a biological entity is 
integrated with the physicochemical responses of the hydrogel. Biologically responsive, 
or bioresponsive, hydrogels operate by first sensing the chemical activity of a biological 
specie in its environment, through catalysis or binding, and then couples the biomolecular 
recognition to transduction of that information with a response that seeks to restore 
equilibrium or a pseudo-steady state within the hydrogel 
[198]
. In this sense, they are 
Generation 2 drug release platforms that supersede Generation 1 drug release platforms, 
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which rely on loading and passive release of a drug from an engineered microform. Of 
particular interest is the use of micro- and nano-hydrogels to sense and respond to 
spatiotemporal perturbations of biological activity as this enables the development of 
therapeutics and diagnostics at molecular and cellular length scales. Such systems are 
well described and are actively pursued in the literature. The development of drug 
delivery systems that are based on self-regulation and that are made responsive to an 
externally derived or environmentally-based biological activity that dictates the release 
rate of the drug has long been a goal of drug delivery designers 
[237]
. This is particularly 
relevant in glucose-responsive insulin delivery, wherein the rate of release of insulin may 
be governed by the bathing concentration of glucose, analogous to an all synthetic 
artificial pancreas 
[238]
. Recently, an in vivo demonstration of this objective that uses the 
glucose(sense)-insulin(deliver) system was reported; however, engineering control of key 
delivery parameters of such systems are unexplored 
[239]
. 
Generation 3 drug delivery systems go beyond environmental control of the 
release rate to focus attention on achieving physiological stasis of the biological species 
that is the target of drug action. Self-regulated delivery systems imply a nascent ability to 
change release profile pursuant to the amount of or extent of release. Generation 3 
systems use the released drug to modulate the activity of the actuating biological factor. 
In this sense, it is distinguishable from self-regulating systems whereupon the release 
kinetics are controlled by the environmental conditions. The Generation 3 drug delivery 
system actually controls the environmental conditions and seeks to achieve homeostasis, 
that is, it targets achievement of a particular activity of the actuating biological specie 
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within the environment that had elicited the release response in the first place. This 
requires the implementation of feedback control. 
The information flow from sensing to response in Generation 2 bioresponsive 
hydrogels often involves dynamical concomitant perturbations such as chemical 
reactions
[238]
 or binding events 
[239]
; diffusive, convective and/or migratory transport of 
species 
[240, 241]
; mechanical deformation 
[242]
; and optical density changes 
[243]
. Due to the 
high interdependency of such changes within bioresponsive hydrogels, explicit solutions 
derived from constitutive mathematical relations are invariably difficult and more often 
unresolved. Thus, the approach to engineering and optimization of bioresponsive 
hydrogels is commonly in vitro or in vivo experimentation coupled with mathematical 
simplifications for analysis. This approach, while effective, can be time intensive and 
may result in suboptimal systems.  Fortunately, the exponential increase in computational 
power over past decades is enabling numerical resolutions to constitutive relations, which 
were previously inaccessible
[244]
. The coupling of Finite Element Modeling (FEM) with 
bioresponsive hydrogels to investigate previously difficult or inaccessible relations has 
and will continue to be a robust and fruitful area of research 
[245-247]
. The complexity of 
the models has scaled in parallel to increasing transistor density and has offered insights 
into these systems. Initially, due to limited computational power, only uni-physical 
models were explored, such anisotropic drug transport in complex geometries 
[248, 249]
. 
However, complete multiphysics models are currently being developed in silico to inform 
the engineering of bioresponsive hydrogels 
[250]
. 
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To this point, an in silico model of enzymatically mediated release from a 
bioresponsive hydrogel was developed and is presented. The three-step process of release 
occurs by (1) diffusion of an enzyme to and into a hydrogel matrix, (2) enzymatic 
cleavage of a tethered peptide-prodrug conjugate that is a substrate specific to the 
transported enzyme and (3) subsequent diffusive release of the active drug into the local 
environment. In vitro variations of enzyme mediated release include the use of pendent or 
polymer-backbone integrated substrates 
[251, 252]
, degradation or gelation of the hydrogel 
matrix 
[253, 254]
 and dynamic swelling or collapsing of the hydrogel matrix 
[255, 256]
. This 
work explores a nondegradable bioresponsive hydrogel with a pendant peptide substrate-
prodrug which when cleaved, activates and releases an active drug. The model was 
validated by direct comparison of its results with previously published in vitro results 
achieved for the release of a model chromophore, para-nitroaniline, by the enzyme 
chymotrypsin 
[237]
.  
Furthermore, the utility of the model was demonstrated by the design and 
optimization of a drug delivery platform that focuses on achieving stasis in the biological 
activity of the external enzyme that is inhibited by the released active drug. This platform 
requires the implementation of, in addition to the above three steps, closed-loop feedback 
coupling the release of the drug to the activity of the sense enzyme. The foregoing is a 
requirement for Generation 3 classification. The particular implementation was 
parameterized for the release of a competitive protease inhibitor, MAG283, via cleavage 
of Acetyl-Pro-Leu-Gly|Leu-MAG-283 by MMP-9 in order to achieve targeted 
homeostasis of MMP-9 activity via closed-loop feedback control. This is relevant for the 
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pathophysiology of chronic wounds where normal metabolic activity has been elevated to 
levels incompatible with acute wound healing.  It is estimated that 1-2% of the population 
will suffer from a chronic wound in their lifetime 
[257]
. In 2009 it was estimated that 
chronic wounds affect 6.5 million patients and the annual treatment cost is estimated to 
be $25 billion.  Compounding the impact on society are disabilities, such as limb 
amputation and loss of wages estimated at $39 billion, that result from the inability to 
quickly and appropriately treat the disease to mitigate these problems 
[258]
.  The 
developed model identified key engineering parameters for the delivery platform, which 
could address a chronic wound environment. Homeostatic drug delivery, where the focus 
is no longer just using drug release rate to achieve targeted control of biochemical 
activity within a biochemical pathway, represents a new paradigm in controlled drug 
delivery and may be called Generation 3 Drug Delivery Devices 
[198]
. 
3.2. Methods 
3.2.1. Modelling Approach and Setup 
The in silico model was designed to match the physical, chemical and reactive 
properties of a previously synthesized in vitro bioresponsive hydrogel 
[237]
. Briefly, the in 
vitro hydrogel system was comprised of a 2-hydroxyethyl methacrylate (HEMA) based 
hydrogel. Transport properties of the polymer matrix were altered by changing the mol % 
of the crosslinker tetraethyleneglycol diacrylate (TEGDA) which dictated the degree of 
hydration, void fraction and tortuosity of the hydrogel. The chromogen (peptide-
chromophore conjugate) N-succinyl-Ala-Ala-Pro-Phe p-nitroanilide (AAPFpNa) was 
covalently attached to the polymer matrix by an amide bond formed using the coupling 
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reagents, 1-ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride (EDC) and N-
hydroxysulfosuccinimide sodium salt (Sulfo-NHS). Upon exposure to the enzyme, 
chymotrypsin, the peptide was cleaved and the chromophore, p-nitroaniline, was 
activated and released into the bathing solution wherein its concentration was measured 
using UV-Vis spectroscopy (λ= 380nm, α = 10,430 M-1cm-1).  
In silico modeling was performed using COMSOL Multiphysics 4.2a software 
and data analysis was performed within MS Excel 2010 and Matlab R2012a. The model 
was designed such that a hydrogel disk was immersed in a bathing solution of enzyme at 
time, t0. The enzyme then diffused into the hydrogel matrix wherein an enzymatic 
reaction (cleavage of the tethered peptide-chromogen conjugate) modeled by Michaelis–
Menten kinetics occurred and the activated chromophore then diffuses out into the 
bathing solution, Figure 3-1. Parameters for the model were made dependent on the 
Figure 3-1:  Three step process of enzymatically releasing a chromophore from a 
bioresponsive hydrogel. (Left) Diffusion of enzyme from solution into hydrogel matrix. 
(Middle) Cleavage of chromophore–peptide bond to activate and release chromophore. 
(Right) Diffusion of chromophore out of hydrogel matrix. 
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mol% of crosslinker and these were determined experimentally or through theoretical 
relations, Table 3-1.   
Table 3-1:  Parameters used in the in silico simulation of enzyme mediated drug release.  
Parameter Value Units Description 
%TEGDA 1% 5% 7% 9% 12% % Mol percent TEGDA 
            
   ++ 12.07 12.07 12.07 12.07 12.07 nmol 
Initial amount of chromogen in 
hydrogel 
            
   
 71.01 134.72 163.85 180.15 160.55 uM 
Initial concentration of 
chromogen in hydrogel 
         
    0.02 0.02 0.02 0.02 0.02 mM 
Initial concentration of enzyme 
in solution 
     
++ 0.81 0.65 0.61 0.58 0.58 (cm) Diameter of hydrogel disk 
     
++ 0.33 0.25 0.23 0.23 0.26 (cm) Height of disk 
            5.59 0.887 0.440 0.256 0.140 ×10
-8 (cm2 s-1) Effective diffusivity of enzyme  
               * 30.9 4.90 2.43 1.41 0.774 ×10
-8 (cm2 s-1) 
Effective diffusivity of 
chromophore 
    † 3.55 3.55 3.55 3.55 3.55 s
-1 
rate constant for Michaelis-
Menton rate equation 
  † 0.75 0.75 0.75 0.75 0.75 mM Michaelis-Menton constant 
         23.3 23.3 23.3 23.3 23.3 kDa Molecular Weight of Enzyme 
             
138.1
2 
138.12 138.12 138.12 138.12 Da 
Molecular Weight of 
chromophore 
     1 1 1 1 1 cm
3 Solution volume 
 ++ 0.78 0.69 0.58 0.52 0.38 - Void fraction of hydrogel 
*Calculated using Stokes-Einstein relation 
†Experimentally determined using methods described in [237] 
++
From previous work 
[237]
 
The hydrogel was modeled as a static, non-swelling, porous scaffold which 
followed from the assumptions that (1) the polymer is not temperature or pH sensitive, 
(2) the hydrogel was non-degradable and (3) any chemical changes to the hydrogel 
matrix due to peptide cleavage has negligible influence on hydrogel swelling as the 
concentrations of the immobilized peptide conjugates are much smaller than the 
concentrations of the pendant groups of the polymer. It should be noted that all previous 
experimental data was gathered under constant physiological-like conditions, T = 37
o
C, 
pH = 7.4.  
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3.2.2. Model Validation and Sensitivity Analysis 
Negation of mesh size effects on the model was verified by comparing the 
solution concentration of the chromophore at t∞ to the theoretically expected value when 
all chromogen has been converted to chromophore, Equations (44).  Error from the 
theoretical value was calculated by Equation (45).   
             
                      
   (         ) 
(44) 
 
      |  
       
   
              
   |        (45) 
Where             
   
 is the initial concentration of the chromogen in the gel, 
              
    is the final concentration of the chromophore in the solution and      and 
     are the volumes of the gel and solution, respectively. Increasing the number of 
elements to approximately 10
4
 was found to sufficiently reduce model error from 
numerical approximations for all cross-linked densities, see Appendix‒B, Figure‒1.  
Additionally, decreasing mesh sizing around the hydrogel-solution interface efficiently 
improved the model performance as the interface region included large gradients that 
contributed to overshooting. 
A sensitivity analysis was performed to determine which reaction-transport 
parameters had the greatest effect on the hydrogel release performance. The values of 
Deff,enzyme, Deff,chromophore, KM and kcat were systematically altered to one order of magnitude 
above and below their original values by taking twenty monotonically spaced values of 
each parameter between the maximum (original value×10
1
) and minimum (original 
value×10
-1
). Sensitivity was measured by comparing the sum of the squared differences, 
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SoS, in the release profile for a step change, n, in the parameter, Equation (46), results 
shown in Appendix‒B, Figure‒2. 
       ∑   
 
   
 
(46) 
Where    
 is the squared difference in the release profile n and release profile n+1 at 
time t.  
3.2.3. Investigation of Diffusion-Reaction Effects Through Transport Modeling 
Three approaches were taken to investigate the modeling of the enzymatically 
mediated release of the chromophore.  First, a pure transport model was investigated 
which only took into account diffusion of the enzyme into the hydrogel matrix 
subsequently neglecting reaction effects. For mathematical simplicity, a monolithic 
solution model for diffusion in the radial direction was used, Equation (47).  It assumes a 
homogenously distributed chromogen within the releasing material that is below its 
solubility limit 
[231]
. The validity of this model is based on the hypothesis that the 
diffusion of the enzyme into the hydrogel is the rate-limiting step and consequently is the 
primary phenomena regulating the release. Equation (47) was fit to release profiles by 
varying Deff,enzyme to maximize the coefficient of determination, r
2
.  
   
  
  (
            
   
)
  ⁄
 
            
  
 (47) 
Where    and    are the cumulative amount of drug released at time t and ∞, 
respectively, and R is the radius of the cylinder. 
The second model, based on the Thiele modulus, Equations (48) ‒ (50), is a 
diffusion-reaction model, which accounts for enzyme diffusion and coupled reaction 
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kinetics 
[106]
. This model neglects the diffusion of the chromophore by assuming it occurs 
quickly relative to the other processes. Additionally, it approximates the enzyme catalytic 
reaction as a first order reaction with the reaction specific rate constant,   
    
  
.  
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 (50) 
Where η is the effectiveness factor, rapparent is the experimentally measured rate, rintrinsic is 
the rate of reaction of the enzyme in bulk solution of substrate, φ is the Thiele modulus, 
and α is geometrically dependent constant (α(slab) = 1,  α(cylinder) = 2, α(sphere) = 3).  
The effective diffusivities were determined previously from the Thiele modulus.  
Finally, through numerical approximation, a diffusion-reaction-diffusion model 
that accounts for enzyme diffusion, Michaelis-Menten type kinetics and chromophore 
diffusion, was used to fit the release data. A nonlinear least squares (NLLS) method was 
used to provide an iterative approach to converge on appropriate value of Deff,enzyme for the 
model. A value of Deff,enzyme was first guessed, and then the in silico simulation was run 
and an r
2
 value calculated. A new value of Deff,enzyme was then estimated using a Newton-
Raphson approach to converge on a Deff,enzyme value which maximized r
2
. 
3.2.4. Model Extension to Homeostatic Drug Delivery 
After validation of the previously developed model, its utility was extended by 
developing and optimizing an in silico drug delivery platform which could be used to 
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achieve normal homeostatic conditions in chronic wounds that could lead to wound 
closure. The pathology of chronic wounds is rooted in increased activity of matrix 
metalloproteinases (MMPs), enzymes responsible for simultaneous degradation and 
reconstruction of the extracellular matrix (ECM), resulting in the inability to reestablish 
the ECM support for cellular proliferation 
[259, 260]
. Specifically, elevated levels of MMP-
9 have been found in chronic wounds, and it is hypothesized that attenuation of the 
enzyme activity to normal metabolic levels should lead to acute wound healing 
[261-263]
. 
To this end, an in silico bioresponsive hydrogel was simulated which released an MMP-9 
inhibitor, MAG-283, from an immobilized MMP-9 peptide-inhibitor conjugate, Acetyl-
Pro-Leu-Gly|Leu-MAG-283 (PLG|L-MAG283), to result in attenuation of MMP-9 
activity in the local bathing environment.  
Figure 3-2:  2-dimenional representation of simulation setup for homeostatic drug 
delivery using MMP-9 peptide-inhibitor conjugate to effect chronic wound environments. 
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The model used a spherical geometry for the hydrogel, as fabrication techniques 
for nano- to micron-sized hydrogel spheres are readily available 
[264-266]
. A single 
hydrogel sphere, shown in blue in Figure 3-2, was placed inside an open boundary 
system, which maintained a volume, Rboundary = f(Vsystem), of 100× the hydrogel volume to 
approximate an infinite boundary. At the boundary, the concentration of the enzyme was 
fixed to approximate a continuous flux of enzyme being eluted and generated from 
surrounding cells. A close-packed configuration of hydrogel spheres was assumed, and a 
second radius, Reff, was used to represent the maximum distance over which the enzyme 
activity needed to be attenuated. All relative enzyme activities were determined at this 
distance. This geometric configuration represents an idealized case; however, Jain et al. 
have shown how sphere densities can be controlled in wound environments through 
chemical immobilization techniques 
[267]
. Additionally, the system may be simulated and 
optimized for other geometric configurations. The extent of attenuation at Reff was 
measured as a percentage by taking the ratio of the amount of free enzyme available for 
reaction, [E]a, given by Equation (51) for competitive inhibition, to the total amount of 
enzyme, [E]T. 
 
     
    
  
   
  
 
   
  
 
(51) 
The inhibitor used was MAG-283, which is a competitive inhibitor of MMP-9 
with a KI value of 2.2 nM 
[268]
.  The kinetic parameters of the peptide-inhibitor conjugate 
were based on the peptide, Acetyl-Pro-Leu-Gly-Leu-(3-[2,4-dinitrophenyl]-L-
,2,3diaminopropionyl)-Ala-Arg-NH2, which has a KM and kcat value of 4.22 μM and 4.23 
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s
-1
, respectively 
[269]
.  The solution diffusivity of the MAG-283 was estimated using the 
Stokes-Einstein relation, Equations (52) ‒ (54) [106]. Using the porous media model, 
Equation (55), in conjugation with the Stokes-Einstein relation and assuming the 
reflection and partitioning coefficients to be equal for MAG-283 and p-Nitroaniline, the 
effective diffusivity of MAG-283 inside the hydrogel matrix was calculated. The 
determined values were 2.62×10
-7
 and 5.41×10
-6
 cm
2
s
-1
 for the hydrogel and solution, 
respectively.  The effective diffusivities of MMP-9, Deff,MMP-9, were estimated by relating 
known effective diffusivities of the previous enzyme to their respective molecular 
weights as described and was calculated to be 4.90×10
-8
 cm
2
s
-1
, for 1mol% TEGDA, and 
4.90×10
-7
 cm
2
s
-1
, similar to literature values 6×10
-7
cm
2
s
-1 [270]
,
 
for the hydrogel and 
solution, respectively.   
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(55) 
Where Rg is the ideal gas constant, T is temperature in Kelvin, μ is the viscosity of the 
solution, a is an estimate of the molecular radius, ρ is the density of the peptide or protein 
which is assumed to be 1 g cm
-3
, MW is molecular weight, NA is Avogadro's number, KP 
is the partition coefficient, KR is the reflection coefficient, ε is void fraction and τ is 
tortuosity.  
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3.3. Results and Discussion 
3.3.1. Model Sensitivity 
Transport of enzymes through hydrogel matrices for biologically mediated release 
is a dynamic process, which involves diffusion-reaction phenomena; additionally, 
complexities may arise from protein fouling 
[271, 272]
, alternation of reaction kinetics 
[273]
, 
or enzyme accessibility 
[274]
.  Here, an in silico model of biologically mediated release 
from a hydrogel is simplified to account for diffusion and reaction phenomena only.  The 
effects on the system of three processes, diffusion of the enzyme into the hydrogel, 
reaction and activation of the chromogen/chromophore and diffusion of the chromophore 
out of the hydrogel, were investigated to determine which process and parameter(s) affect 
the model the greatest.  Figure 3-3 shows the resulting SoS as calculated by Equation (46) 
as a function of TEGDA mole% and the normalized parameter.  The values for Deff,enzyme, 
Figure 3-3:  SoS values as determined by Equation ( 3 ) for Deff,enzyme (Red), 
Deff,chromophore (black), KM (green) and kcat (purple).  Threshold value of for any value 
below 0.01 was set for graphical purposes. 
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Deff,chromophore, KM and kcat were normalized to the values in Table 3-1.  Large values of 
SoS indicate high sensitivity while small values indicate low sensitivity. 
By independently varying the parameters Deff,enzyme, Deff,chromophore, kcat and KM by 
one order of magnitude away from the experimentally or theoretically estimated values, it 
was apparent that the model was most sensitive to the Deff,enzyme since the SoS value was 
approximately an order of magnitude higher than of any of the other parameters at all 
cross-link densities. Additionally, the model was least sensitive to Deff,chromophore and 
moderately sensitive to kcat and KM. This validates the NLLS approach of fitting the 
transport models by varying Deff,enzyme since orders of magnitude changes to the other 
parameters was required in order to influence the model as much as were incremental 
changes in Deff,enzyme. The high sensitivity to Deff,enzyme was an expected result as it was 
previously determined that the diffusion of the enzyme into the hydrogel matrix was the 
rate limiting step. While the high sensitivity for Deff,enzyme was expected, this attribute of 
the system may change depending on the kinetic parameters and geometric scale. 
3.3.2. Investigation of Diffusion-Reaction-Diffusion Effects Through Transport 
Modeling 
Three approaches were taken to investigate modeling of the enzymatically 
mediated release: monolithic solution, Thiele Modulus and NLLS fit.  After 
determination of Deff,enzyme for each approach, the values were implemented in the in silico 
model and the results were compared to experimental results. The determined parameters 
for Deff,enzyme and associated r
2
 value for all three methods are shown in Table 3-2, and in 
vitro () and in silico(―) release profiles for each method is shown in Figure 3-4A-C. 
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From Table 3-2 and Figure 3-4, it is apparent that the monolithic solution approach 
performed poorly as negative r
2
 values indicate the mean of the data provides a better fit 
than the proposed monolithic solution equation.  In enzyme-mediated release, only 
accounting for diffusion of the enzyme into the matrix is not sufficiently robust to 
accurately model such systems. The Thiele modulus approach exhibited a marked 
improvement in the r
2
 values calculated for the goodness of fit for the in silico to the in 
vitro profiles.   
Table 3-2:  Deff,enzyme as determined by different modeling approaches.  r
2
 values reported 
for goodness of fit between in silico release profile and experimental release profile. 
%TEGDA 
Monolithic Solution Thiele Modulus Nonlinear Least Squared Fit 
Deff,enzyme 
(cm
2
s
-1
 ×10
8
) 
r
2
 
Deff,enzyme 
(cm
2
s
-1
 ×10
8
) 
r
2
 
Deff,enzyme 
(cm
2
s
-1
 ×10
8
) 
r
2
 
1% 250.11 -3.89 6.90 0.93 5.59 0.97 
5% 41.53 -25.32 1.40 0.56 0.89 0.98 
7% 30.42 -57.82 0.60 0.77 0.44 0.95 
9% 14.88 -82.59 0.40 0.62 0.26 0.96 
12% 8.79 -133.78 0.10 0.56 0.14 0.84 
 
The increase in r
2
 can be attributed to the inclusion of reaction kinetics in addition to 
enzyme diffusion in the model. It is of particular interest that the model performed 
sufficiently well for approximating the reaction as first order rather than by Michaelis-
Menton kinetics. This suggests that [S] is sufficient small and subsequently may be 
approximated as a first order reaction.  Finally, the NLLS approach resulted in the best fit 
of the in silico profiles to the in vitro profiles.  This is expected as the approach seeks to 
maximize r
2
 by varying Deff,enzyme. While it can be argued that any parameter in the model 
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could have been changed to achieve this result, the sensitivity analysis showed that only 
minimal changes to the value of Deff,enzyme were required to affect the profiles. Conversely, 
if other parameters were varied from their experimentally or theoretically determined 
values, orders of magnitude changes would have been required.  Overall, the use of a 
NLLS fit in conjugation with a sensitivity analysis proves to be the best approach for 
modeling enzyme-mediated release; however, reasonable computation expense is 
required for the finite element modeling.  The value of this in silico model is that it 
allows the exploration of a wide range of scientifically relevant parameters at very little 
experimental expense.  Here, the Thiele modulus approach has been compared to a full 
multiphysics modeling approach, and it is shown that the Thiele modulus may be 
adequate as a first approximation. 
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Figure 3-4:  Experimental release profiles (  , diamonds) and numerical solutions to 
release profiles ( ─ , solid lines) resolved with Deff,enzyme calculated by (A) Monolithic 
Solution, (B) Thiele modulus and (C) NLLS. 
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3.3.3. Homeostatic Drug Delivery Considerations for Chronic Wound Environment 
Homeostasis is achieved through complex, regulated interdependent control 
systems intrinsic to metabolic pathways within the body. When normal metabolic 
function deteriorates, therapeutic drugs may be administered to restore homeostatic 
conditions.  To improve the efficacy of therapeutic drugs, it is desirable to deliver them 
locally and in metabolically relevant rates and amounts through drug delivery systems 
[198]
.  With the advances in hydrogel delivery platforms, this may now be achievable 
through bioresponsive hydrogels with closed-loop feedback control. The general process 
of such a system will involve the three previously discussed steps for release, and a fourth 
step, which is the inhibition or activation of the relevant enzyme and subsequent 
reduction or up-regulation of its activity. The engineering of such a system is complex as 
it involves a balance between the rate of catalysis, transport and inhibition. Therefore, 
such a system was investigated in silico for possible application in the treatment of 
chronic wounds where attenuation of enzyme activity through closed-loop control could 
reestablish normal wound healing. 
The effect of hydrogel radius, R, effective diffusivity of MMP-9, Deff,MMP-9 and 
loading concentration of the peptide-inhibitor conjugation,     
   
, were studied. These 
parameters were chosen as they are easily manipulated through manufacturing processes 
and represent the most amenable engineering control parameters.  Additional parameters 
that affect the system, are enzyme kinetic parameters kcat, KM and KI. While changing the 
peptide or inhibitor used in the delivery system can alter the system’s response, the range 
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of values for these parameters and the substitution of the peptide or inhibitor may be 
undesirable in an in vivo application.   
It was demonstrated that under closed-loop control, local MMP-9 activity could 
be reduced and maintained at a pseudo-steady state level (PSS) achieving homeostatis.  
To reach a PSS, a minimum amount of     
    was required, Figure 3-5.  As the loading 
concentration was increased, a PSS was achieved, and its persistence over time positively 
correlates with loading concentration. By increasing     
   
, the time to react all of the 
species within the hydrogel was extended which extends the period of inhibitor release. 
Additionally, it was found that the level of attenuation,         ⁄ , negatively correlates 
with hydrogel radius. As radius was increased, the volume in which the enzyme reaction 
occurred increased. This results in a larger flux of inhibitor into the local environment, 
further reducing the MMP-9 activity level.   
Figure 3-5:  Attenuation profiles of MMP-9 under closed-looped control as a function of 
peptide-inhibitor conjugate concentrations (dark spheres representing low and 
concentration and lighter spheres representing high concentration) and hydrogel radius. 
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While     
    and R are key design parameters, the system was under reaction 
limited conditions; apparent from calculation of the Thiele modulus at initial conditions, 
and transport parameters become increasingly important as R is increased.  The relation 
between R and Deff,MMP-9 was investigated further to show significant reductions in the 
PSS relative enzyme activities that could have significant therapeutic applications, Figure 
Figure 3-6:  (A) Relative enzyme activity levels as a function of hydrogel radius and 
enzyme effective diffusivity.  (B)  Temporal relative enzyme activity levels for feedback 
control systems operating in reaction limited, transition, and diffusion limited domains 
(C) Enzyme activity as a function of hydrogel radius and enzyme concentration. (D) Low 
(Diurnal) and high frequency enzyme activity cycle and the modulated response of the 
controlled enzyme activity as function of time. 
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3-6A.  When R was small, PSS attenuation levels primarily depended on R and show 
little dependence on Deff,MMP-9; however, as R was increased, the level of attenuation for 
different values of Deff,MMP-9 diverge. This divergence in attenuation was due to increased 
influence of transport phenomena with the effective diffusivities of 4.9×10
-8
 and 7.1×10
-
10
 corresponding to 1 and 12mol% TEGDA, respectively. When R was large and Deff,MMP-
9 was small, the system became diffusion limited which reduced inhibitor release rates 
consequently reducing the level of enzyme activity attenuation.  
Phenomenological domains of operation can be understood by the use of Equation 
(50) resulting in Figure 3-6C. Setting φ = 1, and keeping Vmax, KM and α constant, a 
parabolic relation between the radius and the effective diffusivity constant is established; 
wherein, the rates of transport and reaction are equal.  Utilizing competitive inhibition as 
a feedback control mechanism, the system is initially, t0, optimized but quickly moves 
into the reaction limited domain as KM is altered to a higher value, KMapp, and the 
reaction rate is reduced.  As peptide-inhibitor conjugate near the surface is consumed, the 
system experiences a transition domain where transport and reaction kinetics are 
equivalent in magnitude.  Finally as more conjugate is consumed, the system moves into 
the diffusion limited domain as the enzyme must travel further into the in interior of the 
sphere to consume unreacted peptide-inhibitor conjugate.  Depending on the domain, the 
relative enzyme activity can vary vastly, as shown in Figure 3-6C, where the effective 
diffusivities correspond to 1, 5, 7, 9 and 12mol% TEGDA with smaller spheres 
representing high mol% TEGDA and larger spheres representing low mol% TEGDA.  
When selecting physical characteristics of a system to achieve a pseudo-steady state, the 
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balanced domain should be avoided as the relative enzyme activity is broad ranging in 
this domain.  By tuning the effective diffusivity, through monomer composition, and/or 
the transport path length (ie. radius), through fabrication methods, the dominant domain 
can be selected.  The reaction limited domain may be selected by choosing small radii 
and high diffusivity constants (ie. low cross-linking), and conversely, the diffusion 
limited domain may be selected by choosing large radii and low diffusivity constants (ie. 
high cross-linking). 
After the key control parameters, being radius and loading concentration, of a 
closed-loop hydrogel delivery system were investigated, the system’s capacity to control 
the local activity in a chronic wound environment was explored.  In chronic wounds, 
MMP-9 activity varies from patient to patient and can range from 1-185 ng/mL with a 
normal level < 1 ng/mL 
[275]
. To restore normal MMP-9 activity, it is required that MMP-
9 activity be reduced independent of patient MMP-9 activity to an engineered set-point.  
Attenuation levels were investigated for a range of MMP-9 activity from 1-200 ng/mL 
and for various values of R, Figure 3-6B.  The results demonstrate the importance of the 
hydrogel radius.  As R was increased, from 20 to 200 μm, the system was increasingly 
able to reduce the local enzyme activity independent of the total enzyme concentration. 
The hydrogel released a larger amount of inhibitor with increasing R thereby reducing the 
PSS’s dependence on the local enzyme concentration.  The final utility of this system is 
demonstrated by Figure 3-6D.   The native enzyme activity is modeled under low 
(diurnal) and high frequency cycling with a peak amplitude of 99.5ng/mL corresponding 
to a MMP-9 activity of 1-200 ng/mL.  While MMP-9 activity within a wound may vary 
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over time, between wound types and/or patients, the engineered drug delivery system is 
robust such that the modulated enzyme activity is constant and controlled to the desired 
set point regardless of a dynamically changing environment.  A spatial distribution of the 
diurnal enzyme activity is provided in Appendix‒B, Figure‒3. This demonstrates an 
advantage over sustained release formulations as they are unable to dynamically respond 
to concentration cycles which may result from fluctuating cellular biochemistry.   
Additionally, the system is designed to maximize the efficacy of the loaded drug as it 
releases the drug “on demand” in response to spatiotemporal changes in MMP-9 activity 
subsequently maintaining a targeted activity.  It should be noted that the in silico 
simulation was performed for only one hydrogel sphere, and “cross-talk” between the 
hydrogel microspheres may occur; however, qualitative effects will remain the same.  
Increasing hydrogel radii and Deff will reduce activity and increasing loading 
concentration for the same radius will increase operational lifetime.  While this is true, 
quantitative values, such as the amount of reduction of relative enzyme activity and the 
value of operational lifetime may change.  Changes will occur if the spheres are close 
enough such that the released and diffusing inhibitor is able to inhibit the activity of the 
enzyme within a neighboring microsphere.  Further enhancements to the in silico 
simulations can be implemented to account for these effects. 
3.4. Conclusion 
Bioresponsive hydrogels are being used more as their development results in new 
functionalities and applications. As these polymeric materials proliferate, the 
interdependencies between fundamental phenomena are continually being investigated to 
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further the core science behind the performance of these polymers and to illuminate 
engineering principles for their design. Here, the relation between reaction and diffusion 
within a hydrogel matrix for enzyme mediated release applications has been investigated 
in silico.  It has been determined that the effective diffusivity is the key design parameter 
for transport limited systems and that the Thiele modulus is a suitable method for 
calculating this parameter when numerical techniques are not available.  Additionally, the 
utility of the model was demonstrated by investigating a drug delivery system aimed at 
chronic wound environments where increased MMP-9 activity contributes to the disease 
pathology 
[275]
. It was shown that a hydrogel microsphere could be designed to achieve 
homoeostatic conditions suitable for acute wound healing. Three key engineering 
parameters were revealed: the effective diffusivity of MMP-9, the radius of the micro- to 
nano-hydrogel microshere and the loading concentration of peptide-inhibitor conjugate. 
The loading concentration (payload), in the reaction limited regime, determines how long 
the sphere will release the drug and the loading has no effect on the resulting relative 
enzyme activity. Conversely, the radius affects relative enzyme activity, Figure 6A. 
Effective diffusivity has an effect on relative enzyme activity; however, it is negligible 
for small radii spheres (<50μm) and for large spheres its effect begins to grow as 
diffusive transport plays an increasingly larger role.  Additional work to develop an in 
vitro model will be to incorporate degradability into the system as pHEMA is a non-
biodegradable polymer.  It was necessary to first work with a non-biodegradable system 
in order to establish and validate the associated transport with reaction model. 
Accordingly, p(HEMA) served only as a developmental platform for the investigation of 
 90 
 
the coupled diffusive transport with reaction kinetics. In the future, approaches will turn 
to PEG-maleimide hydrogels with MMP-degradable crosslinks and MMP-degradable 
pendant drug conjugates as described by Phelps and Garcia 
[189, 276]
.  In silico modeling of 
bioresponsive hydrogels is an emerging trend in drug delivery systems. It will continue to 
be a vital tool to glean insights into complex systems and serve as a method of 
engineering and optimization into the indeterminate future. 
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CHAPTER 4 
2. CONCLUSIONS AND FUTURE WORK 
This work has investigated fundamental phenomena involved in ion release from 
bioresponsive hydrogels and has shown that the key engineering parameters for design of 
a closed-loop controlled drug delivery device can be determined and optimized through 
finite element modeling.  Advances in drug delivery continue to produce lifesaving 
technologies and this trend will continue as research into bioresponsive hydrogels 
produce new insights into their operation and design.  Continuation of the two veins of 
research presented here, release of ionic species from zwitterionic hydrogels and the 
investigation and design of a feedback controlled bioresponsive hydrogel, will produce 
mechanistic understanding and design heuristics for future release constructs. 
By continuing to study ion transport in hydrogels, the fundamental phenomena 
involved in this system will allow for engineering and design of similar polymer 
constructs amenable to controlled release of ionic species.  Experimental work may focus 
on the engineering of polymer pendent groups to control the polymer-ion complex 
formed with divalent cations.   
In this and previous work we have explored only a narrow range of PC content (1 
and 5 mol%). A systematic study that investigates a range of MPC content [(1, 3, 5, 7, 9, 
11, 50 and 100 mol% i.e. poly(MPC)] and that not only investigates ion release but also 
elucidates the relative amount of free and bound water by (DSC), elucidates the structure 
of any two–phase regions that may form e.g. the occurrence of micelle formation as a 
function of composition (neutron scattering), studies ion transport using a two-
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compartment cell in order to obtain the perm-selectivity of the individual ions for each 
hydrogel and the use of electrical impedance spectroscopy to establish the conductivity of 
each ion within the hydrogel will provide further insights.  
In elucidating the temperature dependence of the transport coefficient, a feature 
that is so important to possible insight into mechanism of transport, it will be necessary to 
access a wider range of experimental temperatures. Where the use of ISEs may present 
some limitation, the use of small aliquot sampling of the bathing space and atomic 
absorption spectrometry can provide access to analysis of released concentrations at high 
and low temperatures. 
While phosphoryl choline is biomimetic, it is also zwitterionic and presents a 
simultaneous mix of cationic and anionc sites, the molar distribution of which depends on 
internal pH. To isolate the effect of a single internal anionic charge, this may be achieved 
by systematically varying the mol % of 2-carboxylethyl acrylate (carboxylate anion – 
weaker acid) or other ionic pendent group sodium methacryloyl propyl sulfonate 
(sulfonate anion – stronger acid) to the prepolymer mixture. In this way, the role of a 
fully ionized anionic species may be investigated. Conversely, the isolated effect of a 
single internal cationic charge may be achieved by systematically varying the mol % of 
2-aminoethyl methacrylate (ammonium cation) to the prepolymer mixture. In this way, 
the role of a fully ionized cationic species may be investigated. 
Additionally, designing temperature dependence of the system may allow for 
actuated or controlled release via triggers from environmental cues. To confer 
temperature dependence, any  temperature responsive monomer may be included in the 
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prepolymer mixture; among these are N-[tris(hydroxymethyl)methyl]-acrylamide 
(HMMA) and sulfobetaine methacrylate (SBMA).  Additionally, the temperature 
dependent effects of MPC may be further investigated by repeating work performed here 
with higher MPC mol % hydrogels.  This may allow for the tuning of the diffusional 
exponent’s temperature dependence ultimately resulting in a hydrogels which controls 
transport phenomena through temperature cues.  Further fundamental investigations 
should involve elucidation of the phenomena contributing to the negative apparent 
activation energy.  This may proceed through studies using polymer swelling theory as 
applied to temperature dependent and independent swelling hydrogels.  Others have 
observed the volume phase transition temperature (VPTT) as a likely explanation for the 
phenomena 
[230]
.  Investigation and understanding of the temperature dependent 
thermodynamic properties of MPC containing hydrogels will be necessary to elucidate 
the relationship between polymer swelling and activation energies of transport.  This may 
proceed through temperature and ion concentration dependent swelling, AFM based 
modulus measurements, TGA and use of non-crosslinked polymers in solution phase 
transition determination. 
Further work with feedback control loops for drug delivery using bioresponsive 
hydrogels as the platform can eventually lead to the utilization of this technology in a 
clinical setting, e.g. chronic wound healing.  Before disease specific treatments using the 
technology can be created, in vitro and in vivo demonstration of this system will be 
required.  In vitro research should be conducted to verify the results of the modeling work 
presented here and include degradability as a characteristic of the hydrogel.  The in vitro 
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work may utilize a model enzyme system, such as Trypsin and Trypsin specific peptides 
and inhibitors, or may utilize disease specific enzyme systems, such as MMPs.  To 
demonstrate the viability of a disease specific drug delivery system, diabetic mice, an 
animal model used for chronic wounds 
[277, 278]
, could be used in conjunction with a 
disease specific MMP sensitive bioresponsive hydrogel. The microspheres could be place 
in a hydrogel continuum that serves as a hydrogel wound dressing.  
Research and engineering around bioresponsive hydrogels will continue to be a 
fruitful field.  These materials have become integral parts of drug delivery, tissue 
engineering and biosensing technologies and will continue to produce novel devices 
which ultimately improve patient outcomes.  The continued research and development of 
bioresponsive hydrogels will guarantee further understanding of fundamental phenomena 
guiding sense and respond characteristics as well as allow for design of devices 
unmatched by current technologies. 
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APPENDIX A 
Chapter 2 Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix‒A Figure‒1:  Calibration plots used to relate measure mV to [Ion] for 
Calcium (A) and Potassium (B).  Experimentally determined slopes as a function of 
temperature for Calcium (C) and Potassium (D). 
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Appendix A (Continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix‒A Figure‒2:  Predicted diffusion exponent as a function of aspect ratio for 
cylinders.  Where a is radius and l is cylinder thickness.  Reprinted with permission 
from 
[2]
. 
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Appendix A (Continued) 
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Appendix‒A Table‒1:  Nested ANOVA setup for statistical analysis of ion (Factor A) 
and loading (Factor B) as main effects with Temperature as the nested variable for rate 
constant, kKP, (Top) and diffusional exponent, n, (Bottom). 
 99 
 
Appendix A (Continued) 
n Exponent 
Factor B 
Preloaded Postloaded 
F
ac
to
r 
A
 
K+ 
Temp = 25     0.33 0.19 0.35 0.33 0.38 0.49 0.29 0.25 0.19 0.44 0.19 0.44 
Temp = 31 0.11 0.55 0.39       0.28 0.42 0.43 0.27 0.41 0.30 
Temp = 37 0.68 0.40 0.40 0.42 0.45 0.54 0.30 0.27 0.42 0.35 0.36 0.32 
Temp = 45 0.30 0.41 0.45       0.35 0.38 0.26 0.24 0.38 0.42 
Ca++ 
Temp = 25 
1.00 0.90 1.27 0.59 0.46 0.42 0.51 0.60 0.42 1.45 0.86 0.55 
0.53 0.48 0.67 0.46 0.81 0.61 
      
Temp = 31 
0.80 0.49 1.19 0.72 0.41 0.53 0.74 1.06 1.03 1.02 0.68 0.93 
0.85 0.31 0.69 0.59 0.33 0.60 
      
Temp = 37 
0.44 0.62 0.58 0.63 0.93 0.63 0.66 0.59 0.38 1.02 1.12 1.64 
0.65 0.50 0.33 0.39 0.43 0.46 
      
Temp = 45 
0.43 0.60 0.50 0.36 0.45 0.84 0.82 0.64 0.64 1.09 0.71 1.32 
0.52 0.38 0.60 0.39 0.46 0.69 
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APPENDIX B 
Chapter 3 Appendix 
  
Appendix‒B Figure‒1:  Error in theoretical value of release concentration as a 
function of in silico elements.  (Inset) Increased meshing around gel-solution interface 
helped to increase accuracy which reducing computation expense. 
 101 
 
Appendix B (Continued) 
 
 
Appendix‒B Figure‒2:  Graphically demonstrated method for calculating the Sum of 
Squared, SoS.  
Appendix‒B Figure‒3:  Spatial MMP-9 activity which is undergoing a diurnal cycle 
around a hydrogel sphere without (top) and with (bottom) inhibitory feedback control.  
The target MMP-9 activity for acute wound healing is <1 ng/mL. 
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